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Genetic and epigenetic biomarkers have enormous potential to improve 
healthcare management through their use for prognosis and diagnosis of 
diseases such as cancer. While DNA and mRNA have been studied for 
decades, microRNA emerges as a new class of biomarkers that promises to 
facilitate clinical managements of cancer as well as studies of underling 
mechanisms governing cancer pathogenesis. My research focuses on the 
development of new methods and technologies to tackle the critical barriers 
associated to analyses of DNA and microRNA based biomarkers. This 
dissertation is devoted for development of (1) genetic mutation detection 
method that combines excellent specificity of ligation technology and 
ultrahigh sensitivity of quantum dot (QD) nanosensor-based single molecule 
detection (SMD), (2) nanomaterial-based method for further enhancement of 
QD-nanosensor-based assays and (3) quantitative microRNA detection 
methods that are well customized to provide excellent sensitivity, specificity, 
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Chapter 1: Introduction 
Developed in 1983, Polymerase Chain Reaction (PCR) still remains the most 
widely used technique for genetic biomarker analysis. PCR relies on 
thermostable polymerase to amplify the target template in an exponential 
manner, boosting the signal of rare biomarker molecules to detectable levels. 
Although PCR-based assays are extremely sensitive, they are limited by 
relatively low specificity and low degrees of multiplexing. Non-specific 
amplification caused by mispriming is a common problem for PCR-based 
methods: the polymerase is capable of primer extension in the presence of 
mismatch hybridization, necessitating further verification processes.(1) 
Mismatch hybridization poses a limitation to the multiplexing capability of 
PCR-based methods. The probability of mispriming increases dramatically as 
more primers are introduced to the reaction. In case of quantitative PCR 
(qPCR), the current gold standard in PCR-based assays, multiplexing is also 
limited by the detection method. qPCR, an homogeneous assay that does not 
rely on downstream separation methods, reports the presence of target 
through amplified fluorescence signals, which are difficult to separate from 
one another in the presence of multiple fluorophore species due to their 
relatively broad spectra.  
 This dissertation tackles the above problems through two approaches, 




molecule detection (SMD), an extremely sensitive fluorescence detection 
method that is capable of detecting individual molecules in the sample, to 
compensate for the reduction in sensitivity in a process without PCR. Instead 
of PCR, we employed Gap Ligase Chain Reaction (Gap-LCR) to detect the 
presence of targets in a more specific manner. Due to high specificity of ligase, 
Gap-LCR can easily distinguish single nucleotide differences in target 
sequences, making it an ideal assay for genetic mutation detection. The 
ligation products are further concentrated on quantum dots (QDs) that serve 
as a nanoconcentrator to further boost fluorescence signals. The Gap-LCR 
combined with QD-enabled SMD is a highly specific and sensitive assay that 
distinguishes single nucleotide substitution without a need for PCR. In an 
attempt to ultimately increase the signal-to-noise ratio of fluorescence 
reporting, we collaborated with Dr. Mingwei Chen’s group, at Tohoku 
University in Japan, to establish a method to amplify QD fluorescence signal 
up to 100 times by using nanoporous gold (NPG), a novel nanomaterial that 
concentrates electromagnetic fields in its pores to enhance the extinction 
coefficient and the quantum yield of fluorescence molecules. The strong 
fluorescence enhancement afforded by NPG could potentially reduce the 
current stringent requirements for SMD optical platforms, making SMD a 




 In the second approach, we propose an assay, Ligo-miR, which is 
specifically designed for microRNA, a relatively new class of biomarker. 
MicroRNAs are small RNA molecules with defined sequences, length, and 
terminal chemistry, and are estimated to control up to 70% of protein-coding 
genes through post-transcriptional regulation. Although Ligo-miR is 
incompatible with other types of biomarkers, such as genetic mutations, 
methylation, and messenger RNAs, Ligo-miR best meets the requirements of 
microRNA biomarker detection. Given that most commercially available 
biomarker detection assays detect a few tens of biomarkers simultaneously, 
Ligo-miR was also designed to have similar degree of multiplexing – 24 
biomarkers simultaneously. Similarly to Gap-LCR, Ligo-miR utilizes the high 
specificity of ligase to distinguish resembling sequences: microRNAs within 
the same family (e.g., let-7a, let-7b, let-7c, …). Since microRNAs typically 
exist at higher concentrations than target DNA sequences (typically 10 - 
10,000 microRNAs per cell compared to two copies of, for instance, KRAS 
sequences), linear amplification is enough to detect targets from tissue 
samples. Each step of the assay is optimized to provide most convenient, 
specific, efficient, and unbiased results. The validity of Ligo-miR is also 
verified using a qPCR assay through differential expression analysis. The 
Ligo-miR assay developed in my thesis is in the process of being 




 This dissertation illustrates that while it may not be feasible to 
develop an assay that excels in every facet such as sensitivity, specificity, 
convenience, quantification accuracy and multiplexing, it is possible to 
develop a practical and informative biomarker detection assay by specifically 
customizing enzymatic reactions for a certain class of biomarkers. The work 
in my thesis focuses on biology-driven assay design for biomarker detection, 
rather than searching for biomarkers after developing a technique that could 





Chapter 2: Single Quantum Dot-based Ligation Assay for 
Multiplexed Point Mutation Detection 
Song,Y., Zhang,Y. and Wang,T.H. (2013) Single quantum dot analysis 
enables multiplexed point mutation detection by gap ligase chain reaction. 
Small, 9, 1096-1105. 
2.1 Introduction 
DNA single nucleotide substitutions, also known as point mutations, are 
abnormalities widely found in genomic DNA of various types of cancers. For 
example, point mutations discovered in KRAS genes are closely associated 
with lung cancer, colorectal cancer, ovarian cancer, and other cancer types.(2) 
They are therefore valuable genetic markers for cancer diagnostics and 
prognostics,(3, 4, 5, 6) as well as important predictors of patients’ resistance 
to specific cancer therapies.(7, 8, 9) Currently, the majority of point mutation 
detection techniques rely on PCR amplification of target sequences from 
crude genomic DNA samples. Although highly sensitive, PCR based methods 
are complicated by amplification errors due to mispriming, limited accuracy 
of discriminating single nucleotide variations, and limited multiplexing 
capability.(10, 11, 12, 13, 14) 
Although a number of alternative PCR-free methods, such as the Invader 
assay(15) and rolling circle amplification,(16) have been introduced, ligation-




due to their exceptional specificity on base discrimination and robust 
multiplexing capabilities.(17) A number of variations of ligation assays have 
been proposed for point mutation detection. Ligase detection reaction 
(LDR)(18, 19, 20, 21) employs a set of primers to sense the mutation. Only if 
the primers fully complement the target sequence containing the mutation of 
interest does the ligase join the two primers together to form ligation 
products which are then detected using gel electrophoresis or FRET-based 
approaches.(22, 23, 24)  Although it is highly specific in base recognition, 
LDR has very limited sensitivity. Consequently, LDR is usually combined 
with PCR that exponentially amplifies the ligation product to a detectable 
level. The combined PCR-LDR process significantly improves the assay 
sensitivity but suffers from the complications of PCR. Ligase chain reaction 
(LCR)(25, 26, 27, 28) has been introduced to enhance the sensitivity of 
mutation detection by ligation. Instead of using one pair of primers in the 
case of LDR, LCR uses two pairs of primers to flank both the sense and the 
antisense strands of DNA targets, generating ligation products that in turn 
serve as templates for ligation reaction of the next cycle. As a result, the 
mutation can be easily detected through exponentially amplified ligation 
products even with gel electrophoresis.(29) Despite high sensitivity, LCR has 
not been widely adopted for mutation detection. The primers used in LCR 
would inevitably form primer dimers with blunt ends, which tend to cause 




known as Gap-LCR bypasses the blunt-end ligation by introducing a “gap” 
between the primers hybridized to the target template.(31, 32) The primers 
are intentionally designed to form dimers with sticky-ends, thereby 
eliminating the problem of blunt-end ligation. After filling the gap by DNA 
polymerase, DNA ligase can seal the nick between primers and generate an 
allele-specific ligation product. Previous research results suggest that Gap-
LCR and allele-specific PCR have similar sensitivity, but Gap-LCR generates 
less false positives than allele specific PCR when presented with mismatch 
targets. Gap-LCR achieves this increased specificity by the dual layering of 
ligase based mismatch discrimination on top of polymerase 
discrimination.(31) However, most of the ligation-based assays including 
Gap-LCR rely on cumbersome separation techniques such as gel 
electrophoresis or solid phase-based purification.(33, 34, 35) Such labor-
intensive protocols seriously hinder their applications in routine medical 
diagnostics procedures.  
Although Taqman probes(36, 37, 38, 39) or molecular beacons(40, 41) 
combined with PCR have enabled separation-free detection of DNA targets in 
solutions, incomplete quenching of free probes often leads to high 
fluorescence background and low signal-to-noise ratio.(42) Alternatively, the 
advancement of single molecule spectroscopy (SMS) and single molecule 




sensitivity.(43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53) As opposed to 
conventional ensemble detection methods that measure averaged 
fluorescence from the entire analyte  population, SMS measures fluorescent 
bursts emitted from individual molecules as they pass through a femtoliter-
sized laser detection volume. In SMS, background fluorescence from out-of-
focus molecules and scattered light are minimized by a pinhole incorporated 
to the confocal design. Single molecule coincidence detection(54) is a SMS-
enabled approach for sequence-specific detection of single DNA molecules.  It 
employs two differently labeled oligonucleotide probes to search for a specific 
DNA target.  Presence of the target can be determined by coincident 
fluorescence bursts emitted from the two probes bound to the same target as 
the probes-target hybrid passes the detection volume of SMS. This strategy 
permits direct detection of molecular bindings in a solution without the need 
for separation of free probes from targets. This fluorescence burst coincidence 
detection method has been successfully applied to detection of specific DNA 
sequences,(54, 55, 56) DNA methylation,(57) or microRNA expression.(58)  
In this report, we introduce a single QD-based multiplexed coincident 
fluorescence detection method for PCR-free and separation-free detection of 
point mutations in genomic DNA. The method employs Gap-LCR for 
multiplexed enzymatic reactions to generate mutation-specific ligation 




fluorescence coincidence analysis, without the need for PCR and molecular 
separation. In this method, dye-labeled probes are first used for generation of 
mutation-specific ligation products from genomic DNA templates. Then the 
ligation products are captured by QDs through biotin-streptavidin binding to 
form DNA-QD nanocomplexes. Upon illumination, the nanocomplex emits a 
unique single-dot coincident fluorescence signal that is detected by SMS 
(Figure 2.1A). By performing multiplexed Gap-LCR with multiple sets of 
differently labeled primers, mutation variants can be determined by specific 
patterns of coincident signals measured by multi-color SMS (Figure 2.1B). 
QDs serve as both a high intensity fluorescent label and a nanoconcentrator 
to capture multiple dye-conjugated ligation products for signal amplification, 
which facilitates highly accurate detection of coincident fluorescence events. 
We have demonstrated the method to detect mutations on codon 12 of the 
KRAS gene in human fibroblast and Panc-1 pancreatic cancer cell lines, 
respectively. The assay has demonstrated exceptional sensitivity, capable of 
detecting zeptomoles of targets. 
 
2.2. Results 
2.2.1. Assay Principles 
In the assay, the DNA sample is first subjected to Gap-LCR and then is 




polymerase extends primers only if primers form a perfect match to target 
templates. Following primer extension, the ligase is introduced to join the 
primers into ligation products. A set of four primers (two pairs of 
complementary primers) is used to allow chain reaction. The primer 
annealing, gap filling and ligation processes are then repeated through 
thermal cycling in order to exponentially amplify the target. In contrast, the 
polymerase is not able to elongate the primer to fill the gap if primers and 
target template form mismatch hybridization. Consequently, no ligation 
product is formed in the case of mismatch. Since one of the primers is labeled 
with biotin and another labeled with fluorophore, ligation products which are 
generated by Gap-LCR are labeled with both a biotin and a fluorophore. Such 
ligation products are captured by streptavidin-functionalized QDs to form 
DNA-QD nanocomplexes that are subsequently analyzed using coincidence 
detection. In the coincidence detection platform, the laser beam is focused 
into a femtoliter-sized volume from where fluorescence signals are collected. 
When a DNA-QD nanocomplex diffuses into the laser focal volume of the 
SMS platform, both QD and the fluorophore labeled on the ligation products 
are excited, emitting a coincident fluorescence burst that indicates the 
presence of target template of interest. A pinhole placed in front of the 
detectors is used to reject fluorescence emitted by out-of-focus molecules, 
allowing high signal-to-noise ratio detection and preventing detection of false-




In order for multiplexed detection of single nucleotide polymorphisms, a set of 
five primers that include three common primers and two variant-specific 
primers (Table 2.1) are used to simultaneously detect mutant and wild type 
target (Figure 2.1B). Mutant-specific and wild type-specific primers are 
labeled with different species of fluorophores. Depending on the genotype of 
target template (homozygous mutant, wild type or heterozygous mutant), 
DNA-QD nanocomplexes of different color-combinations are generated and 
are detected using the coincidence detection platform.  
2.2.2. Assay Validation 
We evaluated our assay by detecting KRAS codon 12 GGT → GAT mutation 
using the sample containing mutant targets. Four primers including mutant-
specific primer Apr and common primers Cpr1-3 were used. Apr and Cpr1 
were labeled with Alexa488 and biotin, respectively (Table 2.1). Ligation 
products were generated by Gap-LCR and were captured by QDs. As a result, 
coincident fluorescence bursts were observed in both QD and Alexa488 
optical channels (marked by stars), indicating the presence of DNA-QD 
nanocomplexes (Figure 2.2A, B). In the case of mismatch control, where the 
sample contained only the wild type KRAS target, no ligation product was 
generated as evidenced by the absence of coincident fluorescence burst events 
(Figure 2.2C, D). As mentioned earlier, QDs resulted in stronger fluorescence 




meantime, the fluorescence burst size of Alexa488 was significantly increased 
in case of perfect match because QDs brought multiple Alexa488 dyes 
together to pass through the detection volume at the same time. Therefore, 
QDs did not only serve as nanosensors that confirmed the presence of ligation 
products through coincidence detection, but also act as target concentrators 
that greatly enhanced the signals from labeled fluorophores. The number of 
coincident events was plotted as a function of the threshold applied to 
Alexa488 signal (Figure 2.2E). Since the primers are specific to the KRAS 
mutant, only the mutant samples exhibited detectable coincident events. The 
wild type in this case displayed negligible coincident signals. The specificity 
of the wild type primers was also tested, in which case the coincident events 
were observed in the wild type but not in the mutant samples (Figure S2.2).  
In order to further verify the results obtained using coincidence detection, the 
cross-correlation function(59) G() was calculated based on SMS data of 
Alexa488 and QD according to 
     (1) 
where  was the lag time, IA488 and IQD were the fluorescent intensities from 
the Alexa488 channel and the QD channel respectively, and δIA488, δIQD were 
the deviation of Alexa488 and QD655 intensities from their respective means. 

















correlation between the signals from Alexa488 and QD as evidenced by the 
pronounced peak, which suggested that fluorescence bursts were 
simultaneously detected from both channels as a result of the ligation 
products being generated and captured by the QDs. In contrast, the wild type 
showed minimum cross-correlation because the Alexa488 and QDs moved 
independently through the detection volume in the absence of ligation 
products.  
2.2.3. Assessment of Analytical Specificity 
Figure 2.3 shows the intensity histograms of Alexa488 fluorescence bursts 
detected from three different samples including mutant, wild type and no-
template control. Since ligation was prohibited in the no-template control 
sample, the detected fluorescence bursts should originate only from the free 
Alexa488-labeled primers. The free primers exhibited an intensity level of 
lower than 140 photon counts/ms and a similar result was observed in the 
wild type experiment. In contrast, fluorescence bursts with a much enhanced 
intensity of 500 photon counts/ms or higher were detected in the mutant 
sample. The percentages of Alexa488 fluorescence bursts that were coincident 
with QD fluorescence bursts were calculated as also shown in Figure 2.3.  A 
small number of statistical fluorescence coincident events (2-6%) were 
counted in both the wild type and the control experiments when using a 




signal enhancement, a higher threshold can be imposed to achieve effective 
differentiation of binding-induced coincident signals and the statistical 
coincident signals, greatly enhancing the specificity and accuracy in mutation 
detection. In the current experiment, the statistical background coincident 
signals, which may lead to false positives, can be completely removed when a 
higher threshold (≥ 120 photon counts/ms) is used, thereby achieving near 
100% specificity. The same conclusion can be drawn for detection of wild type 
target as shown in Alexa546 intensity histogram (Figure S2.3). 
2.2.4. Assessment of Analytical Sensitivity 
In order to access the sensitivity of the assay, we tested the assay with 
various amounts of target input (Figure 2.4). A dilution series from 17 
attomole to 170 zeptomole of mutant and the wild type were used as target 
templates. Instead of the Alexa488-labeled, mutant specific Apr primer, we 
used wild type specific primer Gpr, which was labeled with Alexa546, to 
detect the wild type target. As expected, samples with larger amount of 
target input showed higher coincidence count at any threshold due to larger 
amount of ligation products generated in the Gap-LCR reaction. Signals from 
mutant as well as wild type samples with zeptomoles of target input were 
routinely detected above the background of no-template control, 




The proposed QD-SMS Gap-LCR assay has been applied for KRAS 
genotyping in human foreskin fibroblast and pancreatic cancer cell lines 
(Panc-1). Human foreskin fibroblast carries wild type GGT at KRAS codon 12 
while Panc-1 cancer cells carry GGT → GAT mis-sense mutation. DNA was 
first extracted from the cell lines. Then, the mutant was amplified with 
mutant-specific primers and the wild type was amplified with wild type-
specific primers by Gap-LCR. Compared to no-template control, high 
coincident counts were observed in positive samples over a wide range of 
threshold, indicating successful identification of particular genotypes 
(Figure 2.5). 
2.2.5. Multiplexed KRAS Mutation Detection 
In the QD nano-assay, the high detection specificity and sensitivity 
complements its multiplexing capability. The assay was able to differentiate 
between the homogeneous mutant, the heterozygous mutant and the wild 
type by analyzing the sample using differently labeled mutant specific 
primers and wild type-specific primers in a single reaction (Figure 2.1B). The 
experiment was performed at a ligation temperature of 65.1 °C, optimized for 
multiplexed ligation reaction for KRAS codon 12 (Supporting Information 
and Figure S2.4). Four samples, including homozygous mutant, 
heterozygous mutant, wild type, and no-template control, were analyzed and 




settings (see Materials and Methods). For the homozygous mutant, the 
coincident events were observed between QD and Alexa488, but not between 
QD and Alexa546 (Figure 2.6A and B). In contrast, the coincident events 
were only observed between QD and Alexa546 but not between QD and 
Alexa488 in the case of wild type sample (Figure 2.6C and D). For 
heterozygous mutant sample, coincident events were observed with both 
combinations due to the presence of both mutant and wild type alleles 
(Figure 2.6E and F). In Figure 2.7, we also statistically verified that 
coincidence fluorescence bursts obtained from samples containing perfect 
match target templates were significantly higher than samples which didn’t. 
As a result, the combination of the coincidence analysis provided 
unambiguous information for determining the mutational status of the 
sample under investigation. This demonstrates that the assay is capable of 
detecting point mutations in a multiplexed manner with high specificity.  
 
2.3. Discussion 
Herein, we demonstrated a highly sensitive and specific QD nano-assay 
which reveals genotype of the target biomarker in a multiplexed manner. Our 
single molecule approach provides significant values over the conventional 
ensemble measurements. Firstly, perfect match samples with Gap-LCR 




behind free labeled primers) result in same ensemble fluorescence intensities. 
Therefore, conventional ensemble measurements need to rely on an 
additional separation step such as gel electrophoresis or bead-based 
purification in order to isolate ligation products from free primers to 
distinguish signal resulting from ligation products from the background. 
Alternatively, SMS can be used for the examination of individual molecules 
in a homogeneous environment. Therefore, ligation products and free primers 
labeled with the same fluorophore could be easily distinguished from one 
another using coincidence detection in a separation-free manner, which 
greatly improves the sensitivity and simplifies the procedures of the assay.  
Secondly, multiplexing experiment using multiple species of fluorophores also 
greatly benefit from a SMS-enabled approach compared to conventional 
ensemble measurement. While even a minor degree of fluorophores’ emission 
spectra bleed through from one detection channel to the other might result in 
false positive detection in ensemble measurements, SMS is capable of 
circumventing the problem. Conventional fluorescence measurement relies on 
analog fluorescence acquisition. Therefore, when multiple species of 
fluorophores are present in the sample, it is difficult decouple the signal 
obtained from targeted fluorophores and bleed through from other 
fluorophore species. For instance, we confirmed that there is <5% spectra 




ensemble measurement (data not shown). On the other hand, SMS decouples 
the analog ensemble fluorescence signal into digital signals from individual 
molecules. Therefore, by setting the threshold, it becomes possible to totally 
eliminate weak bleed through signals without losing any targeted 
fluorescence bursts, which are significantly stronger than bleed through 
signals and background noise (Figure 2.2B).  
Multiplexing capability of separation-free assays, or the number of genetic 
markers which can be investigated in single reaction, is dependent on 
availability of fluorophore combinations which can be cleanly separated by 
optical filters. On one hand, since most organic fluorophores have relatively 
broad emission spectra, it becomes challenging to optically separate more 
than a few fluorophores at the same time. On the other hand, since the 
emission spectra of QDs are narrow and can be easily separated from each 
other, QD biosensor could be a powerful solution to boost the multiplexing 
capability of separation-free assays. Further improvement in conjugation 
techniques would prove beneficial in order to completely substitute chemical 
fluorophores labeled on DNA with QDs. Specifically, more variations of 
suitable conjugation method are required so that each species of QD can be 
easily, stably, and specifically labeled to target DNA molecules without 






In summary, we demonstrated single-QD, multiple-color coincident 
fluorescence analysis that facilitates multiplexed and separation-free 
detection of point mutations. By combining the high specificity of Gap-LCR 
and high sensitivity of QD-SMS, we successfully detected zeptomoles of 
KRAS codon 12 mutation variants with close to 100% specificity. Such high 
sensitivity eliminated the requirement for PCR pre-amplification from 
genomic DNA. In addition, a tedious separation step commonly required by 
ligation-based mutation assays was circumvented by the integration of 
coincidence detection, which identifies specific target sequence by detecting 
coincident multi-color fluorescence bursts in homogeneous environment. Such 
a highly sensitive, specific, multiplexed separation-free genotyping method 
would prove valuable as novel single molecule approach for genetic mutation 
detection. 
 
2.5. Experimental Section 
DNA Extraction. Genomic DNA was extracted from human foreskin 
fibroblast (CRL-2522, ATCC, Manassas, VA) and Panc-1 cancer cell lines 
using Biosprint 15 DNA extraction kit (Qiagen, Inc., Venlo, Netherlands). 




Oligonucleotides. All the synthetic oligonucleotides were purchased from the 
Integrated DNA Technology and the sequences were listed in Table 2.1. Apr 
and Gpr were labeled with Alexa488 and Alexa546, respectively, at their 5’ 
terminals. Cpr1 and Cpr3 were labeled with phosphate at their 5’ terminals 
for ligation reaction to take place. Primer Cpr1 was labeled with biotin at its 
3’ terminal for coupling with streptavidin-coated QD. All primers were HPLC 
purified. 
Gap-LCR Reaction. Gap-LCR was conducted in 25 l of reaction volume 
containing ThermoPol Buffer (1X); Taq Ligase Buffer (0.25X); NAD 1mM; 
dGTP (10 M); dATP (10 M); MgCl2 (3 mM); Taq DNA Polymerase (1.25 
units, New England Biolabs); Taq DNA Ligase (10 units, New England 
Biolabs); various amounts of mutant and/or wild type templates (synthetic or 
genetic DNA extracted from cell lines); common primers (60 nM, Cpr1 – 3) as 
well as discrimination primers (Apr and/or Gpr). The mixture was first 
incubated at 94 °C for 2 minutes, and then thermal cycling was conducted for 
60 cycles at 94 °C for 30 seconds (denaturation step) and 65.1 °C for 60 
seconds (ligation step) unless otherwise noted (Supporting Information). 
After thermal cycling, Taq DNA polymerase and Taq DNA ligase were 
inactivated by incubating the sample at 94 °C for 30 minutes. Ligation 




Coupling of QD and Ligation Products. Qdot 655 streptavidin conjugate 
(QD655), which has a peak emission wavelength at 655 nm, was purchased 
from Invitrogen (Carlsbad, CA). QD was first diluted to 1 nM with phosphate-
buffered saline without calcium & magnesium (1X, Invitrogen). The ligation 
products were then mixed with QD at 30:1 biotin:QD ratio in order to 
generate DNA-QD nanocomplex. Since each QD had 40-80 biotin binding 
sites, all biotin-labeled DNA molecules could be captured by QDs (supporting 
information). After 20 minutes incubation in dark at room temperature, the 
nanocomplex was further diluted to 50 pM using PBS. Later, the samples 
were dispensed into 96-well plate with glass bottom for SMS measurements. 
All tubes were washed with BSA solution (0.1 %) and were baked at 70°C 
degrees for 15 min before use. 
Coincident Fluorescence Detection. Coincident fluorescence detection was 
conducted using Zeiss LSM 510 Confocal microscope (Figure S2.1). 488 nm 
Argon laser and 543 nm Helium-Neon Laser were used to excite Alexa488 
and Alexa546, respectively. Both lasers were capable of exciting QD655. The 
488 nm laser and 543 nm laser were kept at 7.2 mW and 1.2 mW, 
respectively, at all time. A C-Apochromat 40X/1.2 water immersion objective 
was used to focus the laser into the sample contained in the 96-well plate and 




molecules and scattered light. Fluorescence emitted from in-focus molecules 
was separated by dichroic mirrors to fluorescence emitted from fluorophore 
labeled on ligation product (Alexa488 and/or Alexa546) and from QD. 
Fluorescence light was then respectively filtered by emission filters (EF) and 
subsequently detected by avalanche photodiode (APD). Measurements were 
conducted for 180 seconds for each sample. 
Coincidence Analysis. Acquired data were analyzed by a customized program 
written in LabView (National Instrument, Autstin, TX). Individual 
fluorescence bursts were first identified by applying threshold to raw single 
molecule data. Fluorescence signals which exceeded the threshold were 
recognized as true fluorescence bursts. Coincident fluorescence bursts were 
then identified as a pair of simultaneous fluorescence bursts from both QD 






2.6. Tables and Figures 
Table 2.1. Oligonucleotide. 
 
Code  Description  Sequence (5’ to 3’)  
KAS  A segment in mutant type KRAS codon 12 gene 
sense strand (GGT → GAT)  
AAT ATA AAC TTG TGG TAG TTG GAG CTG ATG 
GCG TAG GCA AGA GTG CCT  
KAA  A segment in mutant type KRAS codon 12 gene anti-
sense strand (Complementary to KAS)  
AGG CAC TCT TGC CTA CGC CAT CAG CTC CAA 
CTA CCA CAA GTT TAT ATT  
KGS  A segment in wild type KRAS codon 12 gene sense 
strand  
AAT ATA AAC TTG TGG TAG TTG GAG CTG GTG 
GCG TAG GCA AGA GTG CCT  
KGA  A segment in wild type KRAS codon 12 gene anti-
sense strand (Complementary to KGS)  
AGG CAC TCT TGC CTA CGC CAC CAG CTC CAA 
CTA CCA CAA GTT TAT ATT  
Apr  Alexa488 labeled discrimination primer for GGT → 
GAT mutant KRAS detection 
A488-CAC TCT TGC CTA CGC CAT C  
Gpr  Alexa546 labeled discrimination primer for wild type 
KRAS detection 
A546- CAC TCT TGC CTA CGC CAC C  
Cpr1  Common primer 1 labeled with phosphate and biotin  p CTC CAA CTA CCA CAA GTT TAT ATT-Biotin  
Cpr2  Common primer 2  AAT ATA AAC TTG TGG TAG TTG GAG CT  






Figure 2.1. Schematic drawing of the point mutation detection assay.  
(A) The mutant-specific primer is labeled with a fluorophore and a common 
primer is labeled with biotin. In case of a perfect match (flow illustrated by 
black arrows), primers hybridize to the mutant target template (black strand) 
with a gap in-between. The polymerase fills the gap and then the nick (black 
triangle) is sealed by the ligase. The ligation product serves as a target 
template in the next cycle of the thermal cycling, leading to exponential 
increase of target template. After Gap-LCR reaction, streptavidin-coated QDs 
are introduced to form DNA-QD nanocomples, which give rise to coincident 
fluorescence bursts when analyzed in single molecule coincidence detection 
platform. In case of a mismatch (flow illustrated by white arrows), the 
primers do not hybridize stably to wild type target templates (striped strand). 
As a result, no ligation product is formed and captured by QD, as evidenced 
by absence of coincident fluorescence bursts. (B) Multiplexed detection of 
homozygous mutant, wild type and heterozygous mutant. Mutant and wild 
type-specific primers are introduced simultaneously. The presence of mutant 
is evidenced as coincident fluorescence burst from Alexa488 (blue) and QD 
(red) channel. Similarly, presence of wild type target is evidenced as 












Figure 2.2. Detection of KRAS mutant target.  
(A) Mutant was detected as evidenced by coincident fluorescence bursts 
(marked with stars) from Alexa488 (blue) and QD (red) channels. (B) 
Enlarged view of coincident fluorescence bursts from panel (A). Regions 
specified with green slits were enlarged. Because each QD captures multiple 
ligation products, signal from Alexa488 was significantly enhanced (arrows). 
(C) Mutant-specific primers do not form perfect match with wild type target. 
Therefore, no coincident fluorescence bursts were observed. (D) Enlarged 
view of QD fluorescence bursts from panel (C). Arrows indicate unamplified 
Alexa Fluor488 fluorescence bursts observed from free primers. (E) 
Coincident fluorescence bursts at various thresholds. (F) Cross-correlation 
analysis of QD and Alexa488 signals reveals a strong correlation for the 












Figure 2.3. Specifcity assessment of KRAS wild type detection. 
Histograms of Alexa488 fluorescence bursts detected from perfect match 
(mutant sample, shown in densely striped bars), mismatch (wild type sample, 
shown in sparsely striped bars) and no-template control samples (black bars) 
in 180 second-measurements. The number above each bar presents the 














Figure 2.4. Sensitivity assessment. 
Detection of serial dilutions of (A) mutant target and (B) wild type target. 
The normalized coincidence count is defined as the number of coincidence 
bursts divided by the number of total QD bursts observed within the 













Figure 2.5. Detection of KRAS sequence from cell line DNAs. 
KRAS codon 12 point mutation detection from genomic DNA samples. (A) 
GGT → GAT mutant detection from genomic DNA extracted from pancreatic 
cancer cell line (Panc-1). (B) Wild type target detection from genomic DNA 












Figure 2.6. Multiplexed point mutation detection.  
Coincident fluorescence bursts (marked with starts) from Alexa488 (blue) and 
QD (red) channels suggest the successful detection of mutant target in 
homozygous mutant sample (A) and heterozygous mutant sample (E). 
Coincident fluorescence bursts from Alexa546 (green) and QD (red) channels 
suggested the successful detection of wild type target in wild type sample (D) 
and heterozygous mutant sample (F). Coincident Fluorescence bursts were 













Figure 2.7. Analysis of multiplexed point mutation detection.  
The asterisk, double asterisk, and triple asterisk indicate that p-value is less 
than 0.05, 0.01, and 0.001, respectively, in Student’s one-tailed T-test. The 
error bar indicates standard deviation of three measurements. (A) Detection 
of mutant target. Only homozygous mutant sample and heterozygous mutant 
sample showed significant number of coincident fluorescence bursts. (B) 
Detection of wild type target. Only wild type sample and heterozygous 










2.7. Supplementary Information 
Ligation temperature optimization. In order to optimize the ligation 
temperature in the assay, we conducted multiplexed point mutation detection 
using three ligation temperatures, 64.4, 65.1, and 65.8 °C (Figure S2.4). The 
following four samples were tested with the assay: homozygous mutant, wild 
type, heterozygous mutant, and no-template control. At 64.4 °C, the assay 
detected mutant sequence from homozygous and heterozygous mutant 
samples and wild type sequence from wild type and heterozygous mutant 
samples. However, template-independent amplification was observed from 
no-template control sample at this temperature (Figure S2.4A). Template-
independent amplification was suppressed when the ligation temperature 
was increased to 65.1 °C or higher (Figure S2.4A, B). When the ligation step 
was conducted at 65.8 °C, much less coincidence bursts were observed from 
all four samples because of the reduced activity of Taq DNA Ligase and 
weaker primer-target template hybridization. Therefore, we concluded that 
65.1 °C was the optimum ligation temperature for multiplexed detection of 
mutant and wild type KRAS sequences. 
DNA-QD conjugation. It is important that all biotin-labeled DNA molecules 
are captured by QDs so as to prevent false-negative reaction results. In order 
to accomplish this objective, we incubated DNA with QD whose total biotin-




solution. Since each QD has 40-80 biotin binding sites, we incubated biotin-
labeled DNA and QD at 30:1 ratio. Under this condition, we expect each QD 
molecule to capture approximately 30 DNA molecules in fairly consistent 
manner. Inconsistent DNA-QD conjugation could possibly result from either 
(1) inconsistent QD sizes (and hence surface area) or (2) insufficient mixing. 
However, neither of them is likely. (1) We expect the QD size to be fairly 
uniform because QD emission spectra, which are dependent on QD sizes, are 
narrow. (2) Mixing is expected to be efficient and uniform because both DNA 







Figure S2.1. Multi-color fluorescence burst coincidence analysis 
platform.  
The laser beams are focused into the sample solution contained in 96 well-
plate by an objective. Fluorescence emitted from single molecules is collected 
by the objective, separated by dichroic mirror (DM) by spectrum, filtered by 
emission filter (EF) and detected by avalanche photodiode (APD). A Pinhole 











Figure S2.2. Detection of wild type KRAS sequence 
Wild type-specific primer set (Cpr1-3 and Gpr) was used. Only wild type 










Figure S2.3. Specifcity assessment of KRAS wild type detection. 
Histograms of Alexa546 fluorescence bursts detected from perfect match 
(wild type sample, shown in sparsely striped bars), mismatch (mutant sample, 
shown in densely striped bars) and no-template control samples (black bars) 
in 180 second-measurements. The number above each bar presents the 












Figure S2.4. Ligation temperature optimization for multiplexed point 
mutation detection.  
Detection of mutant target (A) and wild type target (B) using three ligation 











Chapter 3: Enhancement of Quantum Dot Fluorescence by 
Nanoporous Gold (NPG) 
Zhang,L., Song,Y., Fujita,T., Zhang,Y., Chen,M. and Wang,T.H. (2014) Large 
enhancement of quantum dot fluorescence by highly scalable nanoporous gold. 
Adv Mater, 26, 1289-1294. 
3.1 Introduction 
Nanoengineered metallic materials have been shown to have a number of 
exclusive physicochemical properties not available at neither larger (micro- 
and macroscopic) nor smaller (molecular) scales. Recently, these materials in 
particular have drawn significant attention due to their capability to enhance 
fluorescent signals of nearby fluorescent species through a phenomenon 
known as metal enhanced fluorescence (MEF). MEF originates from the 
localized surface plasmon resonance (LSPR), a collective oscillation of 
conduction-band electrons that can modify both the extinction coefficient and 
quantum yield of adjacent fluorescent molecules/species.(60) The extinction 
coefficient is a function of the electromagnetic field intensity experienced by 
the fluorescent molecules, and under an enhanced electromagnetic field, 
fluorescent molecules absorb photons and promote electrons into excited 
states at accelerated rates. LSPR of metallic nanostructures can also modify 




rate. The combined enhancement of extinction coefficient and quantum yield 
can result in significantly strengthened fluorescence from fluorescent species.  
 Most MEF materials developed thus far are targeted for enhancing 
fluorescence from organic fluorophores,(61, 62, 63, 64, 65) and few have been 
developed for inorganic fluorescent species such as quantum dots (QDs). (66, 
67, 68, 69, 70, 71) QDs are distinguished by size-tuneable spectra, large 
Stokes shifts, high quantum yields and great photostability. (72) These 
properties make QDs a desirable candidate for applications in biomolecular 
sensing(73, 74) and cellular imaging.(75, 76) Although MEF can improve the 
detection sensitivity and imaging quality, wide implementation in bioassays 
is obstructed by technological limitations. In particular, fabrication of 
metallic nanostructures for MEF is often not scalable due to the requirement 
of sophisticated equipment and highly specialized personnel.(69) 
Furthermore, conventional MEF materials, such as nanoantennas,(64, 77) 
nanorods(67) and nanoparticles(63, 65, 78, 79, 80) induce large fluorescence 
enhancements only at nanoscopic “hot spots”. (78) Since the sparse hot spots 
constitute only a small fraction of the surface area, the majority of molecules 
reside outside the active region and do not experience MEF. This results in a 
low overall enhancement that is impractical for ensemble fluorescence assays, 
such as microarrays and immunoassays, in which signals are measured 




 In this report, we demonstrate that a three-dimensional free-standing 
nanoporous gold (NPG) film can greatly enhance QD fluorescence. NPG was 
fabricated by a one-step etching process, eliminating the need for a 
sophisticated nanolithography facility. Strong near-field excitation induced 
by NPG enabled ~100-fold enhancement of QD fluorescence, the highest 
demonstrated value to our knowledge. Strong MEF was observed across the 
entire NPG substrate comprising dense and uniform nanoporous structures. 
The broad active region of MEF makes NPG perfectly appropriate for 
ensemble fluorescence assays. In addition, MEF by NPG significantly 
improved fluorescence imaging of QDs at the single dot level. Different QDs 
were found to have different optimum pore sizes for maximum enhancement; 
the QD525 was best enhanced by 38 nm NPG whereas QD605 by 51 nm NPG. 
Importantly, the pore size of NPG can be tailored to a specific QD species by 
simply adjusting etching time.  
3.2. Results and Discussion 
 We fabricated NPG films with various pore sizes ranging from 17 nm 
to 71 nm in average diameter. The NPG films were prepared by selectively 
etching Ag from 700 nm thick Ag65Au35 (at. %) sheets using saturated nitric 
acid at room temperature (Figure 3.1a and b).(81) As nitric acid etches 
silver atoms away from the alloy, a bicontinuous nanoporous structure with 




assembly of residual gold atoms (Figure 3.1c). The as-prepared NPG films 
were carefully rinsed with distilled water. The pore sizes, defined by the 
equivalent diameters of nanopore channels or gold ligaments, can be tailored 
from several nanometers to hundred nanometers by controlling the etching 
time and temperature. The dependence of the pore size on the etching time is 
illustrated in Figure 3.1d. Unlike lithography-based nanomaterials, which 
may suffer from non-uniform UV and temperature exposure, NPG exhibits a 
uniform nanoporous structure with identical ligaments and nanopores across 
the entire substrate (Figure 3.1c). Such high uniformity and broad coverage 
of nanopores contribute to robust fluorescence detection for ensemble 
measurements as well as single QD imaging.  
 We demonstrated the fluorescence enhancing properties of NPG on two 
QD species, QD605 (peak emission at 605 nm) and QD525 (peak emission at 
525 nm). Both QD species are conjugated with streptavidin and have been 
widely used in biomolecular sensing and diagnostics.  Here, the protein 
coating additionally serves as a spacer to prevent metal induced quenching 
by NPG. (66) The distance between QDs and NPG, given by streptavidin, is 
~5 nm which falls into the optimal spacer distance (~5-10 nm) for best 
fluorescence enhancements without obvious quench effect. We used TEM to 
examine the deposition of QDs on the porous surface of NPG after incubation 




deposited over the porous structure without detectable aggregation. The 
semiconductor core of QD605 exhibits an oval shape with a size of 5 nm × 12 
nm while QD525 exhibits a round shape with a diameter of 5 nm.  
 Fluorescence enhancement was first evaluated at the single QD level. 
Figure 3.3a and d show fluorescence images of QDs on NPG taken by a basic 
far-field fluorescence microscope equipped with a CCD camera. Real-time 
imaging of the QDs reveals the blinking characteristics of single QD 
fluorescence (Figure 3.3b and e). The fluorescence intensity of individual 
QDs was determined by the difference in signal level between the “on” and 
“off” states. It is worth noting that all the single QD signals observed in this 
study have a constant fluorescence intensity at the “on” and “off” states. This 
simply rules out the possibility that the individual bright fluorescence spots 
come from two or three different QDs. Figure 3.3c and f are box plots of 
fluorescence intensity of individual QDs on NPG substrates with different 
pore sizes. The result suggests that there is an optimum NPG pore size for 
each of the QDs.  The best enhancement for QD605 was seen from the NPG 
substrate with a 51 nm pore size while QD525 was best enhanced by a pore 
size of 38 nm. The phenomenon was also confirmed by the fluorescence 
intensity histogram of QD605 and QD525 on NPG (see Figure S3.1 in 
Supporting Information). Similar to previous studies on single molecule 




of individual QDs was observed with respect to a specific pore size (Figure 
3.3c and f), which was attributed to the random circumstance of individual 
QDs on the NPG substrate with irregular shapes of nanopores. Because 
polarized excitation light is used in the fluorescence imaging in this study, 
only QDs with dipoles well aligned with the polarization of excitation light 
are best excited while QDs with dipoles vertical to the excitation light 
polarization cannot be excited regardless of fluorescence enhancement effects. 
Additionally, the random nanoscopic structure of the NPG film can also 
induce intensity variation of the LSPR and lead to diverse orientation and 
distance of QDs to the NPG surface, further contributing to the variation in 
fluorescence intensity of individual QDs.  
 We then conducted QD imaging on flat gold substrate without 
nanopores as a control. A much weaker fluorescent signal was detected 
because of a very weak fluorescence enhancement for QD525 and an obvious 
quench effect for QD605 by the non-porous substrate. This weak signal 
necessitated an increased exposure time of beyond 10’s milliseconds to image 
QDs but the resulting poor temporal resolution confounded observation of the 
blinking phenomenon for verifying the single dot events. This result 
demonstrates that the nanoporous structure of NPG plays a vital role for 




 In order to more quantitatively evaluate QD fluorescence enhancement 
by NPG, we deposited a relatively high concentration of QDs (2 nM) on NPG 
substrates and measured the ensemble fluorescence spectra. We verified 
through SEM energy disperse spectroscopy (EDS) that a similar number of 
QDs were deposited on the NPG substrates regardless of pore sizes (see 
Figure S3.2 in Supporting Information) and these QDs were uniformly 
distributed on NPG films (see Figure S3.3 in Supporting Information). A 
micro-Raman spectrometer (Renishaw InVia RM 1000) with an excitation 
laser wavelength of 514.5 nm was used for fluorescence spectra 
measurements, and the laser power was set at a low value of 0.3 mW with a 
laser spot of ~5 μm in diameter. As shown in Figure 3.4a and b, the 
fluorescence intensities of QDs on NPG were consistently higher than those 
on the flat gold substrate and glass slide. Ensemble fluorescence intensity is 
determined by the height of the 605 nm emission peak for QD605 and the 525 
nm emission peak for QD525 in individual spectra. The fluorescence 
enhancement factor Ef(d), as a function of NPG pore size d, was calculated by 
dividing ensemble QD fluorescence intensity on the NPG with pore size d, 
FNPG(d), by ensemble QD fluorescence intensity on glass slide, Fglass: 
Ef(d) = FNPG(d) / Fglass 
Once again, we confirmed that the QD fluorescence enhancement factor is 




enhancements of QD605 and QD525 were achieved from the 51 nm and 38 
nm NPG substrates, respectively (Figure 3.4c and d), which is consistent 
with single QD imaging results (Figure 3.3). The maximum fluorescence 
enhancement factor of QD525 on the 38 nm NPG substrate is as high as ~100 
fold, which, to our knowledge, is the highest reported so far. For QD605, the 
maximum fluorescence enhancement factor of ~50 fold was observed with the 
50 nm NPG substrate.  
 Both results of single QD fluorescence imaging and ensemble 
fluorescence spectroscopy suggest that (1) there exists an optimum pore size 
at which the QD is best enhanced and that (2) the optimum NPG pore size is 
dependent on the QD species. The mechanism underlying these observations 
is unclear but is likely attributable to multiple factors. It is known that the 
spectrum of LSPR induced by NPG strongly depends on its pore size. When 
water is used as the dielectric medium, the peak excitation of NPG can shift 
from 500 nm to 650 nm as the pore size increases whereas the LSPR 
intensity decreases as the nanopore size increases.(83) This red-shifted 
excitation of NPG may be related to the shift of the optimum pore size from 
38 nm for QD525 to 51 nm for QD605. To achieve the best MEF enhancement, 
the emission wavelength of QD525 and QD605 should be close to the LSPR 
peaks of NPG in order to enable optimal coupling. Also, compared with 




system of localized and propagating surface plasmon polarizations (SPPs), 
can induce strongly enhanced local fields from the nearby ligaments and 
scatter efficiently without any loss of energy. The highly enhanced scattering 
fields can be absorbed by QDs, leading to highly amplified fluorescence.(69) 
Besides the double coupling effects, the QD extinction coefficient and 
hydrodynamic radius can also have a significant impact on overall 
fluorescence. In particular, since NPG has a 3D porous structure, a high level 
of enhancement also requires an appropriate geometric match between the 
QDs and nanopore channels. On the one hand, a stronger electromagnetic 
field is concentrated in smaller pores of the NPG,(81) hence contributing to a 
higher extinction coefficient of the QD within the pores. On the other hand, 
NPG with larger pores has a higher probability of accommodating QDs in the 
pores. The combination of the two mutually counteracting effects can also 
lead to an optimum pore size at which the QD fluorescence is best enhanced. 
Likewise, since the physical size of QD525 (~13 nm) is smaller than that of 
QD605 (~13 nm × 20 nm), it is reasonable that the optimum pore size for 
QD525 was smaller than the QD605 counterpart. 
 In this study we investigated the fluorescence enhancement of QDs by 
NPG using both single particle imaging and ensemble fluorescence 
spectroscopic approaches. Compared to non-porous gold substrates, NPG 




fluorescence measurements, we observed 100-fold and 50-fold enhancements 
of fluorescence emitted from QD525 and QD605, respectively. Such high 
levels of enhancement are enabled by both the local surface plasmon 
resonance and propagating surface plasmon phenomena intrinsic to NPG 
substrates. In addition, we also observed a strong dependence of fluorescence 
enhancement on the characteristic pore size of NPG. QD525 and QD605 are 
best enhanced by the 38 nm and 51 nm NPG substrates, respectively. 
Furthermore, NPG permits comprehensive coupling between QDs and 
nanopore channels over a broad substrate area, offering a simple and robust 
material for both single particle and ensemble fluorescence applications.  
3.3. Experimental section 
Sample preparation: 700 nm thick NPG films with various pore sizes were 
prepared by selective dissolution of silver from Ag65Au35 (at. %) alloy leaves 
using 71% nitric acid at room temperature for different time.(81) After 
carefully washing with distilled water (18.2MΩcm), the as-prepared NPG 
films with an area of 2 mm × 2 mm were immersed in the QD solution for 1 
hour, and then used for measurement after washing with distilled water. 
Materials and equipments: CdSe/ZnS core-shell nanocrystals, QD605 (peak 
emission at 605 nm) and QD525 (peak emission at 525 nm) that were 
conjugated with streptavidin were purchased from InvitrogenTM. 




using a scanning electron microscope (SEM, JEOL JIB-4600F) and a 
transmission electron microscope (TEM, JEOL JEM-2100F). Zeiss LSM 510 
Meta confocal microscope was used for single QD imaging, and a micro-
Raman spectrometer (Renishaw InVia RM 1000) with incident wavelength of 







Figure 3.1. Fabrication and microstructure of dealloyed nanoporous 
gold.  
(a) Schematic of the fabrication process of NPG substrates (b) Photographs 
and microstructure of as-prepared NPG films. (c) 3D electron tomographic 
image of a representative NPG film. (d) Tunable ligament and pore sizes as a 
function of etching time. The insets are the top-view SEM micrographs of 












Figure 3.2. TEM images of quantum dots assembled in the nanopore 
channels of NPG. 













Figure 3.3. Measurements of fluorescence enhancement of single QDs 
as a function of pore sizes of NPG.  
(a) Fluorescence image of QD605 on NPG. (b) A 10ms trace of single QD605 
fluorescence. The sudden intensity change (on-off) as a result of fluorescent 
blinking is characteristic of single QD fluorescence. (c) Box plot of single 
QD605 fluorescence intensity on NPG of various pore sizes. The fluorescence 
intensity of each QD is determined as the difference between “on” and “off” 
states. (d) Fluorescence image of QD525 on NPG. (e) A 10ms trace of single 
QD525 fluorescence. (f) Box plot of single QD525 fluorescence intensity on 











Figure 3.4. Ensemble fluorescence enhancement. 
Fluorescence spectra of QD605 (a) and QD525 (b) on glass slide, flat gold and 
the NPG films. (c) and (d) show the QD605 and QD525 fluorescence 
enhancements by the NPG substrates, respectively, as a function of the pore 
sizes. The enhancement factors were determined as the ratio of the peak 
intensity of QDs on the NPG and the glass slide. (e) and (f) show the emission 
peak position of QD605 and QD525, respectively, on the NPG, non-porous 













3.5. Supplementary Information 
Figure S3.1. Histogram of single (a) QD525 and (b) QD605 fluorescence on 
gold film and NPG films with different ligament sizes. (The back fluorescence 
was subtracted from the entire fluorescence intensity. 20pM QD aqueous 









Figure S3.2. Energy Disperse Spectroscopy (EDS) analysis of QD605 
decorated NPG films. The ratio between Zn and Au&Ag is shown in green 
dots, and the red line is drawn for reference. The blue dot shows the relative 
QD amount on glass slide which is evaluated by compare the QD on gold thin 
film coated glass and gold thin film covered QD on glass slide. 2nM QD 










Figure S3.3. Micrographs showing representative morphological of NPG 
flims without and with QDs coating. SEM images of 38nm-NPG films (a) 
without QDs and (b) with QD525. SEM images of 51nm-NPG films (c) 












Chapter 4: Preparing Pre-adenylated Adapter 
Song,Y., Liu,K.J. and Wang,T.H. Efficient synthesis of stable adenylated DNA 
and RNA adapters for microRNA capture using T4 RNA Ligase 1. In 
Preparation. 
4.1. Introduction 
Since the discovery of small RNAs and their significance in various biological 
activities, a number of assays have been invented to specifically quantify the 
microRNA expression of various biological samples. MicroRNA, an important 
class of the small RNAs, are short RNAs that regulates post-transcriptional 
gene regulation. In general, widely adopted assays such as Reverse 
Transcription-quantitative Polymerase Chain Reaction (RT-qPCR) and 
microarray require microRNA modification methods. Since microRNAs are 
too short to manipulate as they are, most modification methods elongate 
microRNAs by either addition of poly(A) tail or ligation of an oligonucleotide 
strand called “adapter”. Among these methods, adapter ligation method is 
most versatile and has been integrated into many microRNA expression 
profiling assays. 
 Typical mature microRNAs are as short as 17 to 24 nt and have 5’-
phosphate and 3’-hydroxyl termini. Their short length and 5’ and 3’ 
functionalities render it susceptible to intra- and intermolecular ligation 




of the microRNA can be ligated together, forming a circularized product 
which cannot be further ligated to an adapter. Alternatively, microRNAs can 
be ligated to other DNA or RNA molecules within the sample instead of 
adapters. In both cases, the side reactions make it elusive to acquire the most 
accurate picture of the microRNA expression profile. A predominant method 
to circumvent the problem has been to ligate a pre-adenylated adapter to 
microRNA molecules using a mutant of T4 RNA Ligase 2 which lacks the 
adenylation capability. Under this method, ligation reaction only happens 
between RNA and “already activated” pre-adenylated adapter molecules, but 
not between target molecules themselves. There has been multiple studies 
devoted for achieving efficient and unbiased adapter ligation to the 
microRNA using various RNA and DNA ligases.(84, 85, 86, 87) 
 Highly efficient microRNA capture is only feasible if pre-adenylated 
adapters could be synthesized in a large quantity and with little impurities. 
The adapter pre-adenylation was first achieved by chemical synthesis, in 
which AMP was activated and adenosine 5’-phosphorimidazolidate was 
coupled to the 5’-phosphorylated oligonucleotide, followed by purification of 
the pre-adenylated adapter from unreacted substrates.(88) Then an 
enzymatic method was invented so as to achieve a higher yield and to reduce 
reaction complexity. In this method, the adapter was first annealed to the 




purified from the template.(89) T4 DNA Ligase 1 catalyzes phosphodiester 
bond formation between the phosphorylated 5’ terminal and the 3’ hydroxyl 
terminal through three steps.(90, 91) The ligase first forms a covalent bond 
with ATP, generating a ligase-(lysyl-N)–AMP intermediate and releasing a 
pyrophosphate. Next, adenylylated RNA (AppRNA) is formed as AMP is 
transferred from the ligase to the 5’-phosphate of RNA. The enzyme lacks the 
specificity to distinguish RNA from DNA; hence this second step reaction 
occurs for both RNA and DNA oligonucleotides. Finally, the ligase catalyzes 
the 3’-5’ phosphodiester bond formation via an attack by an RNA 3’-OH on 
the AppRNA or AppDNA, releasing AMP. If there is no free 3’-OH terminal 
available in the solution, the enzyme eventually leaves the adenylated RNA 
or DNA, which can be used as pre-adenylated adapter for microRNA capture. 
In all of chemical and enzymatic methods above, the laborious purification 
step is a practical obstacle from user’s perspective. A template-independent 
enzymatic method has also been proposed using thermostable Archaeal RNA 
Ligase, which was originally discovered as a ligase that catalyzes 
intramolecular ligation of single-stranded RNA and DNA.(92) This again 
raises fears that Archaeal RNA Ligase carried over from adenylation step 
could cause microRNA circularization in the later microRNA capture step, 
hindering accurate microRNA quantification as a result. Furthermore, while 
the enzyme adenylates the adapter at optimum temperature of 65 ºC, the 




optimum temperature for T4 RNA Ligase 2 truncated used in microRNA – 
adapter ligation reaction, hence reducing the amount of usable adapter in the 
solution.(93) 
 Herein we report a simple single step, purification-free method which 
allows efficient and irreversible adenylation of DNA and RNA adapters using 
T4 RNA Ligase 1. The enzyme can be easily heat-inactivated, posing no 
complication of microRNA circularization or adapter de-adenylation in the 
subsequent microRNA capture step using T4 RNA Ligase 2 truncated. The 
pre-adenylated adapter has been verified to capture microRNAs within total 
RNA samples in a highly efficient and unbiased manner using the protocol 
previously reported in our group.(87) 
4.2. Results 
4.2.1. Adenylation bias due to adapter 
In order to establish an efficient method to adenylate the adapter without a 
need for purification, we chose T4 RNA Ligase 1, which catalyses the ligation 
between DNA or RNA single strands. We hypothesized that the RNA ligase 
conjugates ATP to RNA more efficiently than DNA. In order to test the 
hypothesis, we compared the adenylation efficiency of the enzyme using 5’-
phosphorylated DNA (DNA-A) and a RNA/DNA hybrid (RNA-A) molecules 
(Table S1). While the enzyme did adenylate the RNA/DNA hybrid more 




levels, in which case both adapters were adenylated efficiently (Figure 4.1). 
We further questioned whether the first nucleotide at the 5’ terminal of the 
adapter makes substantial difference in adenylation efficiency. To emphasize 
the difference between adapters, we added large amount of adapter into the 
reaction (10 µM). Under our initial conditions of 10 µM adapter, 1 mM ATP, 
and 100 unit ligase per 1 nanomole adapter, and 1 hour reaction time, the 
adapters that had cytosine and guanine nucleotide at the 5’ terminal were 
the most and least efficiently adenylated, respectively (Figure S4.1), with 
other adapters in-between (data not shown). The adenylation efficiency 
increased as more PEG was added for all adapters tested; however, the 
critical PEG level, at which the adenylation efficiency drastically increases, 
was different depending on the nucleotide at the 5’ terminal. While RNA-C 
adapter was well adenylated at PEG level as low as 5%, DNA-G was much 
harder to adenylate even at 30% PEG level. While an increase of PEG level 
from 20% to 30% enhanced adenylation efficiency significantly for RNA-A 
adapter, the PEG increase hardly meant anything for RNA-C adapter, which 
is already completely adenylated at such PEG levels. Whereas the efficiency 
of the microRNA – adapter ligation reaction using T4 RNA Ligase 2 
truncated decreases at excessively PEG levels(87), a decrease of adenylation 
efficiency using T4 RNA Ligase 1 was not observed as PEG level increased up 




that 35% could be used as a versatile PEG level for all DNA and RNA 
adapters. 
4.2.2. Optimization of enzyme-to-adapter ratio, ATP concentration, 
adapter concentration and time 
Next we examined the effects of enzyme/substrate ratio as well as ATP 
concentration on adenylation reaction. Enzyme/substrate ratio should be 
optimized to keep cost low but still yield sufficiently large amount of 
adenylated adapter. ATP should be close to stoichiometric so that carry-
through is minimized while not reducing adenylation efficiency. It was found 
that 300 unit ligase per 1 nanomole adapter, combined with 1 mM ATP, 
generated highly efficient adenylated adapters within 1 hour (Figure 4.2).  
In order to avoid unnecessary dilution at the stage of microRNA capture, 
adapter solution should be prepared as a highly concentrated solution. To 
examine how much adapter can be adenylated within 1 hour, we changed the 
adapter concentration in the solution while keeping the enzyme amount the 
same. Up to 2 uM of adapter was fully adenylated within 1 hour, again 
corresponding to 300 unit ligase per 1 nanomole adapter (Figure 4.3). With 
longer incubation time (e.g., over-night), DNA-A adapter of 10 uM could be 
fully adenylated (data now shown). 
 For previous reactions, the solution was incubated at 37 °C for 1 hour. 




Figure 4.4, the adapter was found to be efficiently adenylated by incubating 
for as short as 30 minute under optimized 300 unit ligase to 1 nanomole 
adapter and 1 mM ATP condition.  
Under the above-described optimized conditions (35% PEG; 1 mM ATP; 2 uM 
adapter; 300 unit ligase per 1 nanomole adapter; 1 hour reaction time), all of 
RNA-A, RNA-T, RNA-C, DNA-A, DNA-T, and DNA-C adapters generated 
perfectly adenylated adapters within 1 hour (Figure 4.5), whereas DNA-G 
and RNA-G adapters required longer incubation time of 120 minutes (Figure 
S4.2).  
4.2.3. Verification of the adenylated adapter 
The validity of the adenylated adapter was verified in microRNA – adapter 
ligation reaction (Figure 4.6). The DNA-A adapter was first adenylated 
using T4 RNA Ligase 1 followed by heat-inactivation of 65°C for 15 min. The 
adapter was first used to capture synthetic let-7a microRNA that was labeled 
with Cy3 at its 5’ terminal. The capture efficiency, defined as (Cy3 signal of 
captured let-7a band) / (the Cy3 signal of captured let-7a band + the Cy3 
signal of uncaptured let-7a band), was 91%. In addition to synthetic let-7a 
microRNA, the adapter was used to capture RNA molecules within 100 ng of 
the total RNA extracted from human pancreatic tissues. The RNA molecules 
within the extracted total RNA sample was successfully captured by pre-




weight region of the gel. These are likely the ligation products of rRNA and 
the adapter. As a further verification, let-7a microRNA was spiked into the 
total RNA sample and captured by the pre-adenylated adapter using our 
previously described method. In this case, the capture efficiency of the let-7a 
microRNA was 70%. At the same time, large RNA molecules within the total 
RNA were also captured by the adapter as evidenced by the ligation product 
bands in high molecular region in Cy5 channel. This indicates that the pre-
adenylated adapter prepared with the proposed method is fully capable of 
capturing microRNA molecules within the total RNA sample in an efficient 
way. 
As another verification of the adapter functionality, total RNA was captured 
while being titrated from 1,000 ng to 10 ng (Figure S4.3). In addition to 
different amount of total RNA, each reaction also included constant 10 nM of 
six microRNA (miR-let-7a, 16, 21, 26a-1, 29b and 34a) spiked-in. The ligation 
products in high molecular region in the top, again representing total RNA-
derived large RNA molecules captured by the adapter, were linearly 
proportional to the amount of total RNA input. No complication from 
synthetic RNA was observed. This demonstrates that the adenylated adapter 
is able to capture each RNA species proportionally to its presence within the 




4.2.4. Side Product Ligation 
 We compared both the functionality and the side effects of pre-
adenylated adapters synthesized by T4 RNA Ligase 1 and Archaeal RNA 
Ligase. DNA-A adapter was adenylated using either T4 RNA Ligase 1, using 
our proposed method, or Archaeal RNA Ligase, following the recommended 
protocol (https://www.neb.com). The adapter was adenylated at high 
efficiency under both protocols and RNAs were well captured using our 
previously described methods (Figure 4.6 and Figure S4.4).(87) We conclude 
that there was no substantial difference between the two methods in term of 
adenylation efficiency and utility in the microRNA – adapter ligation reaction.  
Next, we examined the side effects of both methods. As previously described 
by multiple groups(92, 93), thermostable Archaeal RNA Ligase adenylates 
adapter at 65 ºC but the reverse (de-adenylation) reaction prevails at non-
optimum temperature such as 37 ºC. Indeed, the adapter adenylation was 
observed during microRNA – adapter ligation reaction by Zhelkovsky, et. al. 
Under our conditions, however, adapter de-adenylation was observed neither 
for T4 RNA Ligase 1-prepared adapter nor for Archaeal RNA Ligase-
prepared adapter (Figure 4.6 and S4). Nevertheless, the other side reaction – 
RNA self-circularization – was observed only when Archaeal RNA Ligase-
prepared adapters were used for microRNA capture (Figure S4.5). In this 




7a precursor sequence that was labelled with 5’-phosphate and 3’-OH and (2) 
the Cy3-labeled let-7a microRNA were used as target. The mixture was then 
incubated with pre-adenylated adapter synthesized by either method. The 
post-microRNA capture sample was analysed using denaturing PAGE gel 
stained with SYBR® Safe DNA Gel Stain (Life Technologies, Carlsbad, CA). 
While the 80 nt-long DNA was long enough to be properly stained by the 
intercalating fluorescence dye, the short let-7a and the adapter were not 
efficiently visualized on the gel. Only when pre-adenylated adapter 
synthesized by Archaeal RNA Ligase was used, circularized DNA band was 
observed on the gel. The amount of the circularized DNA decreased as higher 
PEG levels were introduced to the reaction; however, the circularization 
reaction was not entirely quenched even at 25% PEG, the optimum PEG level 
for microRNA – adapter ligation. 
4.3. Discussion 
In this report we report a quick, simple and robust way to synthesize the pre-
adenylated adapter using T4 RNA Ligase 1 without a need for template or 
subsequent purification steps. The adenylation is irreversible and the enzyme 
can be effectively heat-inactivated prior to the microRNA capture step, 
eliminating the possibility of microRNA circularization. 
 Polyethylene glycol (PEG) is known to enhance the activity of T4 RNA 




level allows for efficient and unbiased ligation between microRNA and 
adapter using T4 RNA Ligase 2 truncated K227Q.(87) In case of microRNA – 
adapter ligation without total RNA, no more increase in the ligation 
efficiency was observed after PEG level reached 25%. In presence of total 
RNA, higher PEG levels could even be detrimental to the reaction efficiency. 
On contrary, in case of adapter adenylation reaction by T4 RNA Ligase 1, no 
reduction in reaction efficiency was observed as higher PEG level was 
introduced to the reaction up to 35%. At 35% PEG level, eventually all 
adapters tested in our report were adenylated for 100% efficiency. 
 Many microRNA detection assays are designed to detect microRNA 
targets from total RNA samples. Since adapter ligation step is non-specific to 
microRNA, other RNA molecules within the sample such as rRNA, tRNA, 
mRNAs and other small RNAs can also be captured by adapters. In other 
words, such “background molecules” compete with microRNA in the ligation 
reaction, suggesting that microRNAs could be “lost” (i.e., not captured by 
adapter and would not be detected) unless the pre-adenylated adapter is 
synthesized and provided in the ligation reaction at a high concentration. We 
previously described that 200 nM of adenylated adapter is enough to capture 
microRNAs from 500 ng of total RNA. Under the proposed method, adapter 




hour of incubation. An even larger amount of adapters can be adenylated if 
longer incubation time is used. 
Although synthesis of pre-adenylated adapter is an essential issue for 
microRNA – adapter ligation step, most methods proposed so far involves 
purification of the pre-adenylated adapter from rest of the molecules, 
including non-adenylated adapters and templates. Purification-free, template 
independent method using thermostable Archaeal RNA Ligase has been 
proposed; however, the method has been shown to have generate de-
adenylated adapter from fully adenylated adapter, suggesting that the 
Archaeal RNA Ligase could be partially active in the microRNA – adapter 
ligation step. This implies another potential drawback caused by the partially 
active Archaeal RNA Ligase during the microRNA – adapter ligation 
reaction: the microRNA circularization. We found it worthwhile to verify this 
possibility because Archaeal RNA Ligase was initially discovered as an 
enzyme that preferentially catalyses RNA circularization.(92) 
To our best knowledge, Archaeal RNA Ligase has never been tested with 
circularization reactions, as a background reaction of microRNA – adapter 
ligation, using a DNA or RNA target which is labelled with 5’-phosphate and 
3’-OH before. Our experiment using 5’ phosphorylated DNA target implies 
that the Archaeal RNA Ligase could potentially introduce circularized RNA 




Ligase prefers RNA targets to DNA targets, suggesting the circularization 
reaction could be even more pronounced for short microRNA molecules. The 
amount of circularized microRNA could be different depending on the 
condition under which microRNA are captured by the adapter. For instance, 
less circularized microRNA was formed when high PEG levels were used. It is 
expected that some microRNAs are more likely to be circularized than others 
due to their sequence or secondary structure, hence introducing additional 
bias in microRNA expression profiling. In such cases, adapter adenylated by 
T4 RNA Ligase 1 could be a safer alternative. 
4.4. Methods 
Oligonucleotides. Both microRNAs and adapters were synthesized by 
Integrated DNA Technologies (Coralville, IA). MicroRNAs, whose sequences 
were taken from miRBase (www.mirbase.org), were labeled with Cy3 and –
OH at their 5’ and 3’ termini, respectively. The adapters were based on 
modified 3' modban adapters and were labeled with phosphate and Cy5 at 
their 5’ and 3’ termini, respectively. All sequences were HPLC purified. The 
sequences are listed in Table S1. 
Adenylation Reaction. Unless otherwise indicated, the adenylation reaction 
was performed in 25 µL solution containing 2 µM DNA-A adapter (Table S1); 
1X T4 RNA Ligase Buffer (New England Biolabs, Ipswich, MA); 35% PEG; 1 




RNA Ligase 1 (New England Biolabs, Ipswich, MA). The solution was held at 
37 ºC for 1 hour and 65 ºC for 15 min for heat-inactivation of the T4 RNA 
Ligase 1. Alternatively, adapter pre-adenylation was conducted using 5' DNA 
Adenylation Kit (New England Biolabs, Ipswich, MA), following the 
instructions from the manufacture. 
microRNA – Adapter Ligation. microRNA was ligated to pre-adenylated 
adapter using T4 RNA Ligase 2 truncated K227Q using the protocol as 
previously described. 
PAGE Analysis. The samples were analyzed on precast 15% TBE-urea 
polyacrylamide gels (Bio-Rad, Hercules, CA). 5 µL of sample was mixed with 
5 µL of loading buffer and heated for 5 minutes at 95 ºC. The sample was 
then loaded into the gel and run for 20 min at 300V. The separated gels were 
scanned using a Typhoon 9410 variable mode imager (GE Healthcare, 
Piscataway, NJ). The gel images were visualized using ImageQuant (GE 





4.5. Tables and Figures 
Table S4.1. Oligonucleotides 
Name Sequence 5' -> 3' 
DNA-A 5' - /5Phos/ACTGTAGGCACCATCAATC/3Cy5Sp/ - 3' 
DNA-T 5' - /5Phos/TCTGTAGGCACCATCAATC/3Cy5Sp/ - 3' 
DNA-G 5' - /5Phos/GCTGTAGGCACCATCAATC/3Cy5Sp/ - 3' 
DNA-C 5' - /5Phos/CCTGTAGGCACCATCAATC/3Cy5Sp/ - 3' 
RNA-A 5' - /5Phos/rACTGTAGGCACCATCAATC/3Cy5Sp/ - 3' 
RNA-U 5' - /5Phos/rUCTGTAGGCACCATCAATC/3Cy5Sp/ - 3' 
RNA-G 5' - /5Phos/rGCTGTAGGCACCATCAATC/3Cy5Sp/ - 3' 















Figure 4.1. The comparison of DNA and RNA/DNA hybrid adapter in 
adenylation reaction under various PEG levels.  














Figure 4.2. ATP and Enzyme optimization.  
A combination of (i) 300 unit ligase per 1 uM adapter and (ii) 250 uM or more 
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Figure 4.3. Adenylation of various amount of adapter.  
The number in the bracket indicates the ratio of unit ligase per nanomole 














Figure 4.4. The yield of adenylation reaction with various incubation 
time.  













Figure 4.5. Adenylation of DNA and RNA/DNA hybrid adapters.  
DNA-G and RNA-G adapters are adenylated less efficiently compared to 
other adapters within 1 hour. 
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Figure 4.6. Demonstration of microRNA – adapter ligation using pre-
adenylated adapter synthesized with T4 RNA Ligase 1.  
Both Cy5-spectra scan (excitation at 633 nm and emission at 670 nm) and 
Cy3-spectra scan (excitation at 532 nm and emission at 580 nm) are 
displayed. DNA-A adapter is effectively adenylated (lane 1: unadenylated 
adapter; lane 2: adenylated adapter) using the proposed method. Let-7a 
microRNA is effectively ligated to the adapter with and without addition of 
100 ng of total RNA extracted from human pancreatic tissue (lane 4 and 6, 
respectively). Large RNA molecules within the total RNA are also captured 
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4.6. Supplementary Data 





Figure S4.1. Adenylation of RNA-A, DNA-A, RNA-C and DNA-G 
adapters with various PEG levels.  
The lower ligase input of 100 unit/µM was used. The adapter is adenylated at 
dramatically different efficiency depending on the first nucleotide of the 
adapter as well as PEG levels. DNA-G adapter and RNA-C adapters are least 



















Figure S4.2. Adenylation of DNA-G and RNA-G adapters with 
extended incubation time.  














Figure S4.3. Capture of RNA molecules within the total RNA sample.  
Total RNA extracted from pancreatic tissues is captured while being titrated 
from 1,000 ng to 10 ng (A). The three ligation products from the top, which 
represent RNA molecules captured by the adapter, are linearly proportional 














































Figure S4.4. Demonstration of microRNA – adapter ligation using 
pre-adenylated adapter synthesized with Archaeal RNA Ligase.  
Both Cy5-spectra scan (excitation at 633 nm and emission at 670 nm) and 
Cy3-spectra scan (excitation at 532 nm and emission at 580 nm) are 
displayed. DNA-A adapter is effectively adenylated (lane 1: unadenylated 
adapter; lane 2: adenylated adapter) using the recommended method. Let-7a 
microRNA is effectively ligated to the adapter with and without addition of 
100 ng of total RNA extracted from human pancreatic tissue (lane 4 and 6, 
respectively). Large RNA molecules within the total RNA are also captured 
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Figure S4.5. Comparison of pre-adenylated adapter synthesized by 
T4 RNA Ligase 1 and Archaeal RNA Ligase in term of DNA 
circularization.  
1 µM of single stranded DNA (80 nt) with 5’-phosphate and 3’-OH is mixed 
into the microRNA – adapter ligation reaction. The gel is stained with 
SYBR® Safe DNA Gel Stain. The DNA, but not let-7a and the adapter, is 
stained and visualized efficiently. Circularized DNA is generated when pre-
adenylated adapter synthesized with Archaeal RNA Ligase is used in the 
reaction. The sample is excited with 488 nm laser and the fluorescence 
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Chapter 5: Capturing microRNA 
Song,Y., Liu,K.J. and Wang,T.H. (2014) Elimination of ligation dependent 
artifacts in T4 RNA ligase to achieve high efficiency and low bias microRNA 
capture. PLoS One, 9, e94619. 
5.1. Introduction 
MicroRNA and other small RNA have added a new dimension to the 
connection between genotype and phenotype. These new mechanisms for 
gene expression regulation have led to a wealth of studies detailing the 
pervasive roles of microRNA in areas such as developmental biology,(95, 96, 
97) stem cell biology (98, 99), cancer,(100, 101, 102) and plant genomics.(103, 
104, 105) MicroRNA are studied both to elucidate their roles in fundamental 
mechanistic pathways as well as to develop novel disease biomarkers (106, 
107) and therapeutics.(108) The majority of microRNA assay techniques been 
adapted from existing mRNA analysis methods. However, due to their short 
length, the first step of nearly all microRNA assays is to modify the 
microRNA through reverse-transcription,(109, 110) poly(A)-tailing (111, 112) 
or  ligation.(89, 113) Among these methods, microRNA capture through 
adapter ligation is a pervasive first step in many PCR-,(107, 114) microarray-
,(115, 116) bead- and sequencing- based assays.(113, 117, 118)  
 Due to the rising popularity of 2nd generation sequencing for small 




microRNA expression profiles across various detection platforms and 
systematically look for sources of bias.(113, 119, 120, 121, 122) Sequencing 
based methods are enjoying rising popularity due to their ability to identify 
small RNA species de novo and due to their ability to distinguish closely 
related isoforms. Although these sequencing approaches typically involve 
many sequential enzymatic steps including reverse transcription, PCR 
amplification, ligation, and poly(A) extension, a number of recent studies 
have pinpointed adapter ligation as the main contributor to expression profile 
bias.(85, 123, 124)  
 Ligation bias is critical because it underlies such a large number of 
microRNA analysis methods. Ligation can introduce two distinct levels of 
bias to microRNA expression profiles. First, bias can be introduced across 
samples when different adapters are used on different individual samples. 
Alon et al showed that consistent differential expression profiles can be seen 
across samples when the same adapter sequence is used but that large 
variations are seen when different adapter sequences are used even within 
the same sample. This can be a significant problem when comparisons are 
made across assay platforms that use different adapter sequences or when 
adapters are used to barcode individual samples such as in multiplexed deep 
sequencing applications. Second, bias can be introduced within each sample 




Hafner et al demonstrated that microRNA species can appear over or under-
expressed by multiple orders of magnitude due to biases in ligation 
efficiency.(84, 124) This is less of an issue in differential expression analysis 
but is a significant issue when comparisons are made across microRNA 
species to rank expression levels. Though the majority of recent studies have 
examined bias in the context of sequencing based methods, this ligation bias 
will have similar effects on other microRNA assays such as PCR and array 
based methods that incorporate 3' ligation. 
 Recent studies have sought to identify the cause of ligation bias and 
remediate it.(84, 85, 123, 125) All of these recent studies have focused on 
improving adapter design to reduce bias. Jayaprakash et al found that two 
terminal bases on the 3' adapter can have dramatic effect on ligation 
efficiency.(85) Zhuang et al and Hafner et al demonstrated that secondary 
structure interactions can contribute significantly to variations in ligation 
efficiency.(84, 86) Remediation strategies have included optimization of ligase 
choice, optimizing secondary structure interactions, and incorporating 
adapter pools.(85, 86, 123, 125, 126) To our knowledge, few studies other 
than Zhang et al have investigated the optimization of reaction conditions for 
bias suppression.(126) Furthermore, nearly all have resorted to the use of 




commonly held perception that T4 RNA ligase is inherently biased and 
difficult to use. 
 In this study, we have designed a microRNA capture method based on 
3' adapter ligation that achieves very high efficiency (86% AVG) and low bias 
(10% SD) across all microRNA species tested. High efficiency capture is 
demonstrated even with microRNA that previous studies have had difficulty 
capturing and even based on the standard 3' modban adapter that previous 
studies have shown to exhibit high ligation bias. Using a panel of 20 
microRNA, we studied key assay parameters such as PEG%, enzyme 
selection, adapter saturation, and design and show that they can be used to 
suppress bias and nearly eliminate ligation preference given suitable 
optimization methodology. We demonstrate that optimization must be done 
in the presence of total RNA using a microRNA panel to minimize global bias, 
as erroneous conditions can be found if optimization is done using only a 
single microRNA or in synthetic conditions. 
5.2. Materials and Methods 
Adapter Oligonucleotides. MicroRNA targets were synthesized by Integrated 
DNA Technologies (Coralville, IA). They consist of HPLC purified, DNA 
oligonucleotides with 5'-Ph and either 3'-ddC blocking group or 3'-Cy5 label. 
The adapters are based on modified 3' modban adapters.(88) The adapters 




similar to Thomson et al.(127) Additional adapters were also synthesized for 
comparison purposes based on the SR1 and SR1-S sequences reported by.(86) 
 
Synthetic microRNA. MicroRNA were synthesized by Integrated DNA 
Technologies (Coralville, IA). The sequences were taken from miRBase 
(www.mirbase.org) and are listed in Table S5.1. They targets consist of 
HPLC purified RNA oligonucleotides derivatized with 3'-OH and 5'-Cy3 end 
groups. 
 
Ligation Protocol. Unless otherwise indicated, ligation was performed by 
mixing 1.25 µL of 2 µM adenylated adapter, 1 µL of T4 RNA Ligase buffer 
(New England Biolabs, Ipswich, MA), 5 µL of 50% PEG8000, 1 µL of synthetic 
target, 0.5 µL of total RNA, 1 µL of T4 RNA Ligase 2 truncated K227Q (New 
England Biolabs, Ipswich, MA) and water into a 20 µL reaction volume. The 
reaction was then incubated at 25 ºC for 4 hours and heat denatured at 65 ºC 
for 20 minutes in a thermal cycler. In the experiments where different ligases 
were investigated, T4 RNA Ligase 2 truncated, T4 RNA Ligase 2 truncated 
R55K K227Q, and Thermostable 5' App DNA/RNA Ligase were all obtained 
from New England Biolabs. In spiking experiments, 500 ng of human brain 





PAGE Analysis. The samples were analyzed on precast 15% TBE-urea 
polyacrylamide gels (Bio-Rad, Hercules, CA). 5 µL of sample was mixed with 
5 µL of loading buffer and heated for 5 minutes at 95 ºC. The sample was 
then loaded into the gel and run for either 30 min or 50 min at 300V. The 
separated gels were scanned using a Typhoon 9410 variable mode imager 
(GE Healthcare, Piscataway, NJ). The gel images were analyzed using 
ImageQuant (GE Healthcare, Piscataway, NJ) to obtain lane profiles. These 
profiles were then curve-fit with Gaussian curves using Origin (OriginLab, 
Northampton, MA) to precisely determine band position and intensity. 
 
5.3. Results and Discussion 
5.3.1. Bias in Ligation Based microRNA Capture 
MicroRNA consist of short RNA sequences that are typically 17 - 23 nt in 
length. Due to their short length, 5' and/or 3' adapter ligation is often used to 
label, capture, or lengthen the microRNA before downstream detection. A 
number of studies have suggested a pooled adapter approach to average out 
the intrinsic effects of ligation bias. However, by improving ligation reaction 




method that achieves high efficiency and low bias microRNA capture without 
the need for adapter pools. 
 As shown in Figure 5.1, an adapter oligonucleotide is ligated to the 3'-
OH of each microRNA using T4 RNA ligase 2. To reduce side product 
formation, the adapter is first enzymatically pre-adenylated such that the 
ligation reaction can be performed in the absence of ATP. This prevents the 
microRNA in the sample from undergoing self-circularization, self-
polymerization, and ligation to RNA species other than the adapter. Second, 
the 3' end of the adapter is blocked with dideoxycytosine (ddC), a fluorophore, 
or other moiety to prevent self-circularization and adapter concatenation. 
Finally, a recombinant mutant ligase is used. These enzymes lack the domain 
necessary for ATP incorporation and contain point mutations that further 
suppress side product formation. Such an approach is commonly used in 
microRNA analysis ahead of reverse transcription.(88, 89, 107, 128) Using 
this general reaction design, we investigated the effects of specific reaction 
conditions in suppressing ligation bias. 
 In order to characterize overall ligation efficiency and ligation bias, we 
synthesized a panel of 20 representative microRNA. Ten of the microRNA 
were selected based on their reported roles as important cancer-related 
microRNA (let-7a, miR-16, miR-21, miR-26a, miR-29b, miR-34a, miR-15a, 




to enable comparison against recent publications (miR-31, miR-338, miR-567, 
miR-4803, miR-5183, miR-712, and miR-106b). For example, Zhuang et al 
reported difficulties capturing miR-4803, miR-5183, and miR-567  while 
Hafner et al reported low capture efficiencies for miR-31, miR-712, and miR-
338.(84, 86) Jayaprakash et al reported that miR-106b could not be captured 
consistently under any of their experimental conditions. The final three 
microRNA were randomly selected (miR-25, miR-125b, miR-19b). Each target 
microRNA was labeled with a Cy3 dye at the 5' end to enable quantification 
of ligation efficiency under spiking conditions in total RNA. The reaction 
products were analyzed using denaturing PAGE, and the gels were scanned 
using a multimode imager. Image analysis was then used to obtain band 
positions and DNA quantity. Using this PAGE analysis method, we obtain 
excellent quantification and reproducibility. Quantification is linear from <5 
amols to >10 pmols with an experiment to experiment CV of 10% (Figure 
S5.1). 
5.3.2. Ligase Type 
The first parameter we investigated was ligase type, as the ligases 
themselves likely have different intrinsic bias. Figure 5.2 shows a 
denaturing PAGE analysis of adapter ligation on our 20 microRNA test panel 
using 4 different RNA ligases. For each ligase, we used the manufacturer 




capture efficiency was easily quantified using image analysis to compare the 
band intensities between the free microRNA band at ~20 nt and the ligated 
microRNA band at ~40 nt.  A quantitative analysis of ligation efficiency for 
each microRNA and each ligase is provided in Figure S5.2. 
 T4 RNA ligase 2 truncated (T4 Rnl2 T) is a mutant enzyme that lacks 
the domain necessary for ATP incorporation, which should significantly 
reduce side product formation when used with pre-adenylated adapters in the 
absence of ATP.(129) As evidenced by the bright uniform bands in Figure 
5.2A, this enzyme gave high ligation efficiency (66% AVG) and low bias (11% 
SD) with every microRNA species being captured at >40%. However, a 
significant number of background products can also be seen on the gel. A 
number of unique and randomly sized bands, which run faster than both the 
captured microRNA and the free adapter, are visible in each lane. It is 
unclear what these products are as typically only circularized products can 
run faster than linear products of the same size, but the same 5'-Cy3 that 
enables visualization should also prevent the formation of such circularized 
products. 
 T4 RNA ligase 2 truncated K227Q (T4 Rnl 2 TK) contains a point 
mutation that is designed to further reduce side product formation.(129, 130) 
This effect is clearly seen in Figure 5.2B, where side product formation is 




bands are no longer apparent. Yet, the overall ligation efficiency has 
decreased dramatically (20% AVG) and ligation bias across the microRNA 
panel is quite significant (25% SD). Six microRNA were captured at <2% 
efficiency.T4 RNA ligase 2 truncated KQ (T4 Rnl 2 TKQ) is a double-point 
mutant that is also designed to have low side product formation but with 
increased ligation activity that is restored to the levels of T4 Rnl2 T.(129) In 
our experiments, little difference was seen between T4 Rnl 2 TK and T4 Rnl 2 
TKQ, which had a capture efficiency of 17% ± 24%. T4 Rnl2 TKQ had 7 
microRNA that were poorly captured at <2% efficiency. 
 Finally, we tried Thermostable 5' App DNA/RNA Ligase (MthRnl) from 
New England Biolabs, which is a point mutant of RNA ligase isolated from 
Methanobacterium thermoautotrophicum. This thermostable ligase is unable 
to incorporate ATP and works optimally at 65 ºC. Ligation at an elevated 
incubation temperature could serve to reduce bias from secondary structure 
interactions. Though the same adapters and microRNAs were used, a 
different pattern of ligation bias was seen. This likely arose from ligation 
preferences intrinsic to the ligase itself. In addition, despite the higher 
reaction temperature, neither ligation efficiency (30% AVG) nor bias (28% 
SD) was significantly improved over the T4 Rnl2 variants. 
 Although T4 Rnl2 T had high ligation efficiency and low bias, the large 




deemed unacceptable. We chose to use T4 Rnl2 TK moving forward due to the 
belief that it would be easier to increase reaction efficiency and reduce bias 
than to suppress side product formation. 
5.3.3. PEG Levels 
Additives such as polyethylene glycol (PEG) (131, 132) and dimethyl sulfoxide 
(DMSO) (89, 115) are commonly added to ligation reactions to increase 
reaction efficiency. In our preliminary experiments, we saw minimal effect 
with DMSO addition (data not shown). However, we saw dramatic effects on 
ligation efficiency and bias due to PEG. PEG is thought to increase molecular 
crowding,(131, 132, 133) and many studies as well as manufacturer protocols 
have recommended ~15% PEG as an ideal concentration.(89, 107) Ligation 
efficiency is said to plateau or even decrease at high PEG levels.  
 Based on the initial results of Figure 5.2B, we optimized the effects of 
PEG on a subset of our 20 microRNA panel. We tested three microRNAs that 
were initially poorly captured by T4 Rnl2 TK, miR-31 (2.5% capture 
efficiency), miR-155 (28% capture efficiency), and miR-4803 (3.5% capture 
efficiency). 10 nM of each microRNA was individually spiked into 500 ng of 
total RNA. This represents about ~3-4 million microRNA copies per cell and 
is sufficient to approximate the aggregate expression of all microRNA within 
the cell. As the PEG concentration was varied from 0 - 35%, Figure 5.3 and 




function of PEG level and then decreased at high PEG levels. MiR-31 and 
miR-4803 behaved similarly, reaching the highest capture efficiency at 25% 
PEG, while miR-155 reached maximum efficiency at 15% PEG. The variation 
seen between these microRNA underscores the importance of optimizing 
reaction conditions across multiple microRNA species. The ideal conditions 
for a single microRNA do not necessarily extrapolate to other microRNA.  
 When the microRNAs were spiked into idealized buffer conditions 
rather than total RNA, a different behavior was seen. Maximum capture 
efficiency was reached at lower PEG levels with miR-31 and miR-4803 
behaving similarly again, reaching plateau at 20% PEG, and miR-155 
reaching plateau at 15% PEG. The overall ligation efficiencies also increased 
significantly, particularly for miR-155.  Total RNA likely contains inhibitors 
that prevent ligation from reaching completion such as: 1) RNA species that 
bind and sequester the microRNA, 2) RNA species that ligate competitively to 
the microRNA, 3) RNA species that ligate competitively to the adapter, 4) 
RNA species that ligate competitively to each other, and 5) inhibitors of the 
ligase. Though our  and reaction design should minimize effects 2), 3), and 4), 
the large amount of background RNA can still occupy the ligase binding site 
even if the actual ligation cannot occur (i.e. ligase shaking hands but not 
making deals). In addition, the decrease in ligation efficiency seen at high 




idealized buffer conditions. It is unclear what the exact mechanism of PEG is 
and why different effects would be seen with and without total RNA spiking. 
Furthermore, the discrepancy in ligation behavior across the three microRNA 
also appears to decrease, with all three microRNA being well captured at 20% 
PEG. 
 This data illustrates that the optimal assay parameters determined 
using 1) a single microRNA vs. a panel and 2) in idealized buffer vs. spiking 
conditions are quite different, highlighting the critical importance of 
optimization methodology and design. Most previous publications, as well as 
manufacturer protocols, have recommended 12-15% PEG. At this PEG level, 
only miR-155 is optimally captured under spiking conditions. In spiking 
conditions, ligation at 20-25% PEG is optimal whereas ligation at the 
recommended 15% PEG leads to very low efficiency. Of all the parameters 
investigated, PEG had the most dramatic effect on ligation bias and efficiency.  
5.3.4. Adapter Concentration and Ligase Amount 
Next we tested the effects of adapter concentration and ligase amount in 
conjunction with one another. Adapter concentration must be in excess to the 
ligated species to drive ligation forward. In addition to microRNA, samples 
often contain other RNA species such as mRNA, rRNA, and siRNA that can 
also be ligated. Having too few adapters will limit the ligation efficiency and 




product formation. In addition, large excesses of free adapters may also 
complicate downstream assay processes. The ligase amount also needs to be 
sufficient to obtain a high ligation efficiency in a reasonable amount of time. 
However, high ligase amounts can promote side product formation as well. 
Practically speaking, ligase is the most expensive reaction component and 
should be minimized to reduce costs. 
 Adapter concentration and ligase amount were optimized by 
quantifying their effects on the capture of miR-31, both in presence and 
absence of total RNA. Figure 5.4 and Figure S5.4 show the effects of 
concurrently varying adapter concentration from 50 nM to 400 nM and ligase 
amount from 100 units to 400 units. In the absence of total RNA, little effect 
was seen by increasing either adapter or enzyme levels. Even at 50 nM 
adapter and 100 units of enzyme, ligation efficiency was 88% due to their 
high excess. However, under the same conditions in the presence of total 
RNA, ligation efficiency drops to 34% due to the large amounts of other RNA 
species in solution that the adapters can be ligated to and that ligase can 
spend time shaking hands with. Under these realistic spiking conditions, 
much larger amounts of adapter and enzyme were needed; 200-300 nM of 
adapter and 200 units of enzyme were needed to reach saturation. Although 




adapter and enzyme, high levels of at least one component also gave 
relatively high efficiencies.  
5.3.5. Incubation Time 
For the previous reactions, a 4 hour incubation was performed. We 
investigated whether this time was sufficient and whether it could be reduced. 
Using miR-31 as a model and the optimized protocol developed thus far, we 
tested incubation times from 30 minutes to 18 hours both in the presence and 
absence of total RNA. Figure 5.5 and Figure S5.5 illustrate the microRNA 
capture efficiency as a function of time. As expected, the ligation reaction 
proceeded much faster in the absence of total RNA, reaching >80% in only 30 
minutes and reaching plateau in <2 hours. When spiked into total RNA, 
plateau was not reached until >8 hours. This was likely due to the greater 
number of RNA species within the sample that the adapters could be ligated 
to. By 4 hours, ligation reached 92% of the plateau value, striking a good 
compromise between incubation time and ligation efficiency.  
5.3.6. Incubation Temperature 
Secondary structure has been proposed as a main contributor to ligation 
bias.(84, 86) We investigated the effect of incubation temperature on ligation 
efficiency and ligation bias under the premise that elevated incubation 
temperatures could potentially reduce secondary structure interactions and 




using MthRnl, we did not see any significant difference when compared to 
ligation at 25 °C using the T4 Rnl2 variants. However, in this case both the 
temperature and the ligase were changed. The intrinsic bias of the MthRnl 
could have swamped out any effects due to temperature.  
 We performed a second analysis using T4 Rnl2 TK while incubating at 
4 °C for 18 hours, 25 °C for 4 hours, or 37 °C for 4 hours. T4 Rnl2 TK is not 
thermostable and is denatured at 65 °C so temperatures beyond 37 °C were 
not tried. Incubation at 4 °C allows for the reaction to proceed for an 
extended amount of time to compensate for decreased enzyme activity. Most 
enzymes recommend incubation at 25 °C. We also performed ligation at 37 °C 
to see if a modest increase in incubation temperature would have any effect 
on bias. Figure 5.6 and Figure S5.6 show a graph and gel images, 
respectively, of the ligation efficiency for all 20 microRNA in our test panel 
using the 4 °C, 25 °C, and 37 °C conditions when spiked into 500 ng of total 
RNA. 
 The highest efficiency and lowest bias were seen at the 25 °C condition 
where ligation efficiency across the 20 microRNA panel was 53.1% AVG ± 
13.7% SD. When the incubation temperature was decreased to 4 °C, the 
ligation efficiency across the panel decreased to 23.6% AVG ± 7.2% SD. 
Despite the increased ligation time (18 hours vs. 4 hours), the decreased 




Interestingly, the capture efficiency CV for the 4 ºC condition (31% CV) was 
only slightly worse than at 25 °C (26% CV), indicating that temperature does 
not have a large impact on bias across this range. The pattern in capture 
efficiency for each individual microRNA in the panel was fairly similar for the 
two conditions except that the capture efficiency at 25 °C was 2x higher in 
most cases. When the incubation temperature was increased to 37 °C, the 
ligation efficiency across the panel dropped to 34.7% AVG ± 17.7% SD. The 
higher incubation temperature reduced the ligase activity but unexpectedly 
increased the bias over both the 4 °C and 25 °C conditions to nearly 51% CV. 
Incubation temperature likely results in a combination of effects on ligase 
activity, ligase degradation, and secondary structure formation that impact 
ligation efficiency in a complex manor. With a few exceptions, the pattern in 
ligation efficiency across the panel was generally similar to the 4 ºC and 25 ºC 
conditions.  
5.3.7. Adapter Design 
Thus far, we've investigated the use of reaction conditions to suppress the 
intrinsic bias of T4 Rnl2 TK. Adapter design can also play a large part in 
ligation bias due to primary sequence and/or secondary structure effects. 
However, the differences in microRNA capture efficiency seen across 
published studies illustrate the unpredictable nature of these interactions. 




inhibitory secondary structures or promote favorable interactions, only 
modest improvements, if any, were seen.(86) In Figure 5.7 and Figure S5.7, 
we performed adapter ligation on the 20 microRNA panel in spiking 
conditions (500 ng total RNA) using four different adapter sequences. First, 
we synthesized two versions of our modified modban adapter (88) to test 
whether having RNA or DNA as the 5' residue would affect ligation efficiency 
or bias. As the ligases used herein are RNA ligases used for single stranded 
blunt end ligations, it is possible that the ligases will have a preference for 
ligating RNA versus DNA. The rA version contains a ribo-A as the 5' base 
while the dA version contains a dexoyribo-A as the 5' base. As seen in Figure 
5.7 left, both of our modified modban adapters achieved high ligation 
efficiencies with low bias. No significant difference was seen between the rA 
or dA versions of the adapter, indicating that T4 Rnl2 TK displays no real 
preference for RNA-RNA ligation or RNA-DNA ligation. The rA adapter had 
a capture efficiency of 68.5% ± 17.6% (AVG ± SD) across the 20 microRNA 
panel while the dA adapter had a capture efficiency of 71.6% ± 15.4% (AVG ± 
SD). Even under spiking conditions, the capture efficiencies surpass what 
previous publications were able to achieve using complex adapter pool 
strategies in idealized buffer conditions. Using the dA adapter, 19 microRNA 
were captured at >50% with the lowest still being captured at 31%. We 
attribute the low capture efficiency of miR-155 to degradation or synthesis 




receiving the target, high ligation efficiencies were obtained which would 
slowly degrade over time. MiR-155 was the only target we saw this effect 
with.  
 Encouraged by the previous results, we synthesized the SR1 and SR1-
S adapters used by Zhuang (86) and Hafner (84) to test whether our reaction 
would work equally well with other adapter designs. SR1 is a standard 
adapter commonly used in Illumina's sequencing products. SR1-S was 
designed by Zhuang to reduce ligation bias by eliminating inhibitory 
secondary structure interactions. As seen in Figure 5.7 right, the overall 
ligation efficiency and bias were much poorer with both of these adapter 
designs.  The SR1 capture efficiency across the 20 microRNA panel was 
49.4% ± 20.6% with only 7 microRNA captured at > 50%. The SR1-S adapter 
fared even worse with only 1 microRNA being captured at >50%. SR1-S had a 
capture efficiency of 16.9% ± 15.2% (AVG ± SD) across the panel. This result 
parallels that reported by Zhuang where the SR1-S adapter unexpectedly 
performed much worse than the SR1 adapter and failed to improve ligation 
efficiencies despite eliminating secondary structure interactions. Given the 
current reaction conditions and microRNA test panel, our modified modban 
adapter appears to work significantly better than the SR1 adapter. It is 
possible that the ligation reaction conditions can be optimized specifically for 




5.3.8. High Efficiency and Low Bias microRNA Capture 
Based on the optimized conditions determined in previous experiments, we 
performed ligation on the 20 microRNA panel using 300 units of T4 Rnl 2 TK, 
25% PEG, 200 nM adapter incubated for 4 h at 25 °C. Ligation was performed 
both in idealized buffer and in total RNA spiking conditions as shown in 
Figure 5.8. Each experiment was performed in triplicate. In the absence of 
total RNA, the capture efficiency across the 20 microRNA panel was 86% 
AVG ± 10% SD. No microRNA was captured at less than 60% with 18 of 20 
microRNA being captured at 70% or greater. This is a considerable 
improvement over the initial conditions of 20% ± 25% (AVG ± SD). 
Optimization of various parameters such as PEG, adapter, enzyme levels, 
and incubation time led to an increase in overall ligation efficiency and the 
concurrent benefit of effectively reducing ligation bias. Saturating levels of 
each parameter tend to push all of the competing reactions toward 
completion, regardless of moderate differences in thermodynamic equilibrium 
and kinetics. Thus, as the capture efficiency of all the microRNA increases 
and approaches 100%, bias is concurrently reduced since capture saturates at 
100%.  
 When compared to previous studies performed in idealized buffer 
background, a significant improvement in average capture efficiency and bias 




miR-155 (90%), and miR-567 (73%) were well captured while miR-31 (48%) 
and miR-338 (3%) were less well captured.(84) In our process, all of these 
microRNA are uniformly captured at 87%, 91%, 60%, 74%, 74%, and 93%, 
respectively. Similar results are seen when compared to Zhuang et al.(86) 
They reported let-7a (100%), miR-31 (87%), and miR-567 (56%) to be well 
captured while miR-4803 (1%), miR-5183 (42%), and miR-712 (8%) were 
poorly captured. All of these microRNA species are well captured with our 
methods at 97%, 74%, 74%, 90%, 97% and 69%, respectively. In addition, 
miR-106, which could not be captured consistently by Jayaprakash et al 
under any conditions, is now captured at 90%.(85) 
 These differences are further pronounced when comparing microRNA 
capture in realistic spiking conditions. The presence of total RNA likely 
reduces capture efficiency due to the aforementioned competitive reactions. 
Under realistic spiking conditions in presence of total RNA, our capture 
efficiency is slightly decreased and bias is slightly increased with a capture 
efficiency of 64% AVG ± 17% SD across the panel. 16 of 20 microRNA have 
capture efficiencies greater than 50%. Only miR-155 had a low capture 
efficiency (27%). We experienced repeatability problems with miR-155, likely 
due to synthesis and degradation, as previously described. In comparison, 
Zhuang et el reported significantly reduced capture efficiencies under spiking 




miR-567, miR-4803, and miR-5183, respectively.(86) To resolve this, they 
proposed a random adapter pool approach to average out the low capture 
efficiencies. However, the capture efficiencies for the pooled approach still 
remained relatively low at 83%, 27%, 8%, 9%, and 14%, respectively. A recent 
study by Zhang et al(126) has also used randomized adapter pools to reduce 
bias. Bias was reduced to1.8-fold from the expected frequency across a 29 
microRNA panel. In comparison, the current method uses only a single 
adapter and achieves highly efficient and low bias capture levels of 74%, 63%, 
61%, 73%, and 83% for let-7a, miR-31, miR-567, miR-4803, and miR-5183. In 
fact, our spiking capture efficiencies surpass what has been demonstrated by 
previous studies under idealized buffer conditions.  
 The experiments shown in Figure 5.8 were performed using a dA 
adapter labeled with Cy5. Additionally, we also performed this experiment in 
triplicate using an rA adapter labeled with Cy5 and an rA adapter blocked 
with ddC (data not shown). In each case, similar results were obtained, 
demonstrating that the adapter ligation process is highly repeatable and 
robust. This is further evidenced by the low average experiment-to-
experiment SD for each microRNA seen in Figure 5.8, which was 3% in 
idealized buffer and 7% in total RNA spiking. microRNA capture efficiency is 










Figure 5.1. Schematic illustration of microRNA capture by 3' adapter 
ligation.  
The 19 nt, enzymatically pre-adenlyated adapter probe is ligated to the 3' OH 
of microRNA using T4 RNA ligase 2. The reaction is run at 25 °C for 4 hours 
in the absence of ATP. In order to characterize capture efficiency, the 
microRNA is end labelled with Cy3. The 3’ end of the adapter probe is 
blocked by –ddC, a fluorophore, or other moiety to prevent the formation of 








T4 RNA Ligase 2
5’-Cy3 3’-ddC
Incubation








Figure 5.2. MicroRNA capture was performed with 4 different ligases 
using the vendor recommended protocols to compare capture 
efficiency across 20 different microRNA.  
The ligation products were analyzed by 15% denaturing urea-PAGE. Capture 
efficiency was determined by performing a Cy3 scan and comparing the 
intensities of the ~40 nt captured microRNA band versus the ~20 nt free 
microRNA band. T4 RNA Ligase 2 truncated (T4 Rnl2 T) had high average 
capture efficiency and low bias but many randomly sized background 
products. The point mutant enzymes T4 RNA Ligase 2 truncated K227Q (T4 
Rnl2 TK) and T4 RNA Ligase 2 truncated KQ (T4 Rnl2 TKQ) had decreased 
side product formation but also lower average capture efficiency and higher 
bias. Thermostable 5´ App DNA/RNA Ligase (Mth Rnl), which was performed 
at 65 °C instead of 25 ºC, had similar average capture efficiency and bias but 



























































































































































































































































































































































































































Figure 5.3. Comparison of ligation efficiency as a function of PEG 
percentage for miR-31, miR-155, and miR-4803 in idealized buffer 
(open markers) and total RNA spiking conditions (filled markers).  
miR-155 and miR-4803 display similar behaviour with respect to PEG 
percentage while miR-31 behaves distinctly. Different behaviour is also seen 
between idealized buffer conditions and total RNA spiking conditions, 
illustrating the importance of optimization methodology in extrapolating 
assay performance. Optimizations performed using a single microRNA 
species in idealized buffer may not extrapolate to other microRNA under 





































Figure 5.4. Optimization of adapter probe and enzyme concentration 
The adapter probe concentration and T4 Rnl2 TK amount were changed 
simultaneously to see their joint effect on the capture efficiency of miR-31. 
The experiment was performed under idealized buffer conditions and total 
RNA spiking conditions which lead to distinct conditions for optimum capture 
efficiency. Under spiking conditions, greater amounts of probe and enzyme 




























































Figure 5.5. Reaction time optimization. 
The ligation reaction was incubated at 25 °C for 30 min to 18 hours to 
investigate the effect of time on the capture efficiency of miR-31 in idealized 
buffer conditions and total RNA spiking conditions. In idealized buffer 
conditions, the ligation reaches completion in < 2 hours. Whereas in spiking 

































Figure 5.6. Temperature optimization. 
Comparison of incubation temperature on capture efficiency across the 20 
microRNA panel. The ligation reaction was incubated for 18 hours at 4 °C, 4 


















































































































































































































































































































































































Figure 5.7. Comparison of capture efficiency across the 20 microRNA 
panel spiked into 500 ng of total RNA using 4 different adapter probe 
designs.  
The rA and dA adapter probes have identical sequences based on modified 
modban probe design except the 5' base is either RNA or DNA as indicated. 
The SR1 and SR1-S adapters are taken from Zhuang et al (39). T4 Rnl2 TK 
shows no preference for DNA or RNA at the ligation site. However, overall 



























































































































































































































































Figure 5.8. The optimized capture efficiency for the 20 microRNA 
panel in idealized buffer conditions and total RNA spiking 
conditions.  
The data is presented as representative gel images and as graphs based on 
image analysis of 3 sets of independent experiments. High capture efficiency 
and low bias are obtained across the panel both in idealized buffer conditions 

















































































































































































































































































5.5. Supplementary Information 





Table S5.1. Oligonucleotides 
The adapter probe was based on a modified version of the modban adapter  
Name Sequence 5'-> 3' 
let-7a 5'- /5Cy3/rUrG rArGrG rUrArG rUrArG rGrUrU rGrUrA rUrArG rUrU -3' 
miR-106b 5'- /5Cy3/rUrA rArArG rUrGrC rUrGrA rCrArG rUrGrC rArGrA rU -3' 
miR-125b 5'- /5Cy3/rUrC rCrCrU rGrArG rArCrC rCrUrA rArCrU rUrGrU rGrA -3' 
miR-155 5'- /5Cy3/rUrU rArArU rGrCrU rArArU rCrGrU rGrArU rArGrG rGrGrU -3' 
miR-15a 5'- /5Cy3/rUrA rGrCrA rGrCrA rCrArU rArArU rGrGrU rUrUrG rUrG -3' 
miR-16 5'- /5Cy3/rUrA rGrCrA rGrCrA rCrGrU rArArA rUrArU rUrGrG rCrG -3' 
miR-17 5'- /5Cy3/rCrA rArArG rUrGrC rUrUrA rCrArG rUrGrC rArGrG rUrArG -3' 
miR-19b 5'- /5Cy3/rUrG rUrGrC rArArA rUrCrC rArUrG rCrArA rArArC rUrGrA -3' 
miR-21 5'- /5Cy3/rUrA rGrCrU rUrArU rCrArG rArCrU rGrArU rGrUrU rGrA -3' 
miR-25 5'- /5Cy3/rCrA rUrUrG rCrArC rUrUrG rUrCrU rCrGrG rUrCrU rGrA -3' 
miR-26a 5'- /5Cy3/rUrU rCrArA rGrUrA rArUrC rCrArG rGrArU rArGrG rCrU -3' 
miR-29b 5'- /5Cy3/rUrA rGrCrA rCrCrA rUrUrU rGrArA rArUrC rArGrU rGrUrU -3' 
miR-31 5'- /5Cy3/rArG rGrCrA rArGrA rUrGrC rUrGrG rCrArU rArGrC rU -3' 
miR-338 5'- /5Cy3/rUrC rCrArG rCrArU rCrArG rUrGrA rUrUrU rUrGrU rUrG -3' 
miR-34a 5'- /5Cy3/rUrG rGrCrA rGrUrG rUrCrU rUrArG rCrUrG rGrUrU rGrU -3' 
miR-4803 5'- /5Cy3/rUrA rArCrA rUrArA rUrArG rUrGrU rGrGrA rUrUrG rA -3' 
miR-5183 5'- /5Cy3/rUrA rUrUrU rGrGrA rCrArA rArUrU rUrGrA rGrUrC rA -3' 
miR-567 5'- /5Cy3/rArG rUrArU rGrUrU rCrUrU rCrCrA rGrGrA rCrArG rArArC -3' 
miR-712 5'- /5Cy3/rCrU rCrCrU rUrCrA rCrCrC rGrGrG rCrGrG rUrArC rC -3' 
miR-92a 5'- /5Cy3/rUrA rUrUrG rCrArC rUrUrG rUrCrC rCrGrG rCrCrU rGrU -3' 
Modban 
Adapter* 
5'- CTGTAGGCACCATCAAT -3' 
SR1 Adapter 5'- TCGTATGCCGTCTTCTGCTTG-NH2 -3' 






Figure S5.1. Characterization of the gel scanner. 
The 19 nt Cy5-labelled adapter probe was serially diluted and analyzed by 
15% denaturing PAGE. A Cy5 scan was performed on a Typhoon imager, and 
image analysis was used to determine band intensity. The experiment was 
repeated 3 times. The fluorescence was linear from <5e-18 mol to >1e-11 mol. 



















































Figure S5.2. Comparison of ligases in microRNA capture 
performance 
Image analysis was performed on the gel data in Figure 5.2 to obtain capture 
efficiencies for each of the 20 microRNA in the panel using T4 Rnl2 T, T4 
Rnl2 TK, T4 Rnl2 TKQ, and Mth Rnl. The reactions were performed using 










































































































































































































































































































































































































































Figure S5.3. Optimization of PEG percentage 
Raw PAGE images depicting the effects of PEG on capture efficiency for miR-
31, miR-155 and miR-4803 in idealized buffer conditions (-RNA) and spiked 
into 500 ng of total RNA (+RNA). PEG was varied from 0% to 35%. Image 
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Figure S5.4. Optimization of adapter and enzyme concentration 
Raw PAGE images depicting the effects of adapter probe concentration and 
enzyme amount on the capture efficiency of miR-31 in idealized buffer 
conditions and spiked into 500 ng of total RNA. Image analysis was 
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Figure S5.5. Raw PAGE images depicting the effects of incubation time on 
the capture efficiency of miR-31 in idealized buffer conditions and spiked into 



































































































Figure S5.6. Optimization of reaction temperature. 
Raw PAGE images depicting the effects of incubation temperature on the 
capture efficiency and bias across the 20 microRNA panel. Ligation was 
performed at 4 °C, 25 ºC, and 37 °C under identical conditions spiked into 500 



























































































































Figure S5.7. Comparison of adapter probe designs in microRNA 
capture. 
Raw PAGE images depicting the effects of 4 different adapter probe designs 
on the capture efficiency and bias across the 20 microRNA panel under 
spiking conditions. The rA and dA adapter probes are based off of a modified 
modban probe design with RNA-A vs. DNA-A as the first letter, respectively. 
The SR1 and SR1-S probes are taken from Zhuang et al (39) and Hafner et al 
























































































































































































































Figure S5.8. Capturing microRNA within total RNAs. 
(A) Let-7a, miR-16, and miR-21 were serially diluted from 10 nM - 0.1 nM 
and captured using the optimized method. The reaction products were then 
analyzed by denaturing PAGE. (B) The capture efficiency was calculated and 
plotted against the input miRNA (capture efficiency = captured microRNA / 
(captured microRNA + free microRNA)). (C) The amount of captured 
microRNA was plotted against the input microRNA level. Both data indicate 


















Chapter 6: Ligo-miR: Multiplexed MicroRNA 
Quantification 
Song,Y., Kilburn,J.D., Qiu,L., Chen,L., Liu,J.K., Meltzer,J.S. and Wang,T.H., 
Ligo-miR: a multiplexed ligation assay for microRNA quantification. In 
Preparation. 
6.1. Introduction 
Personalized medicine has been a holy grail of medical society since complete 
of the human genome project. The dream of every individual receiving 
treatments specifically tailored, based on his/her genetic information, to 
achieve the best possible outcome has invoked much efforts to develop assays 
that detect molecular biomarkers – molecules suggesting medical conditions 
of the patients – from cells and body fluids.  
One class of potential biomarkers that are attracting increasing 
amount of attention is microRNA – the short non-coding RNA that is 
expressed in a wide variety of tissue cells and organisms. Due to their 
profound influence in cellular activities such as cell division and tissue 
differentiation, microRNAs have been suggested to play a key role in cancer 
progression. Many among over 500 validated human microRNAs have been 
proven to be abnormally over or under expressed in cancerous tissues or even 
in body fluids.(134) Such strong link between microRNA expression levels 




biomarkers. MicroRNAs are also robust; they are resistant to digestion in the 
body fluid and formalin embedded tissues.(135) Furthermore, microRNAs 
have been shown to not only distinguish cancerous / non-cancerous states, 
but also hold the potential to classify cancer types – a favourable trait that 
current commercially available messenger RNA (mRNA) biomarker tests 
have yet to demonstrate.(136) Cancer classification is especially powerful 
since it could not only tell whether the patient needs further medical 
examination but also narrows down the tissue that deserves a detailed 
scrutiny.  
Encouraged by the great promise, much efforts have been devoted to 
development of microRNA biomarkers.(137) However, despite substantial 
investment, no microRNA biomarker has been approved by governments for 
clinical purposes so far. One of the reasons behind the modest growth is lack 
of technology that can be used to validate proposed microRNA biomarkers in 
a quick and cost-effective manner.(138) Microarrays is capable of detecting 
thousands of microRNAs at a time, hence serving as a crucial tool for wide 
screening of potential biomarkers. Selected candidates can be studied in 
detail and on individual basis using Reverse Transcription-quantitative 
Polymerase Chain Reaction (RT-qPCR). Although sensitive and quantitative, 
RT-qPCR is costly, tedious, and is typically designed to handle one microRNA 




amount of sample, labour, time, and reagents – quickly multiples if the 
biomarker panel constitutes of multiple microRNAs candidates. Given that 
thousands of patient samples must be tested under the same condition in 
biomarker validation processes, RT-qPCR-based methods turn out to be 
prohibitively expensive and sometimes unrealistic, arresting rapid growth of 
biomarker industry. 
 The biogenesis of microRNA also poses a unique hurdle in expression 
profiling assays. MicroRNAs are first transcribed as long primary microRNAs 
(pri-microRNAs) that are subsequently processed by Drosha. The resulting 
precursor microRNAs (pre-microRNAs) are further processed by the Dicer-
containing complex, finally resulting in mature microRNAs, which, as part of 
RNA-induced silencing complex (RISC), regulates gene expression through 
interacting with mRNA. While functionally active mature microRNAs have 
distinct ~22 nt sequences and are labelled with 5’ phosphate and 3’ hydroxyl 
group, pre-microRNAs have complete mature microRNA sequences but also 3’ 
overhang. Since many microRNA assays including Beadarray(139) and 
Nanostring(140) detect microRNA based on probe hybridization to the 
mature microRNA sequences without a clear reaction step selecting against 
RNAs with the 3’ overhang, there is a shortage of multiplexed microRNA 
profiling assays that yield the true picture of the microRNA expression 




 To overcome above described problems, we have developed a 
multiplexed ligation-based assay for microRNA quantification (Ligo-miR), 
which is capable of quantifying more than 20 mature microRNAs in a robust, 
sensitive and specific way within a single tube. The assay is simple two-step 
reaction with minimum requirement of cost and labour, and is specifically 
designed to detect only mature microRNAs, eliminating complications from 
the precursors. The assay takes advantages of our previously described high-
efficiency, low-bias adapter ligation method(87) and utilizes high specificity of 
DNA ligase in target recognition. While compatible with a wide range of 
downstream analysis, the assay is capable of detecting microRNAs of single-
digit attomoles or from samples equivalent to 2 ng of total RNA on gel-
reading platform. With 20% experiment-to-experiment variability (standard 
deviation), the assay allows for quantification of samples with 1.2-fold 
difference in the target amount. Furthermore, we also demonstrate an 
excellent agreement between the proposed method and the current gold 
standard RT-qPCR assay. We expect Ligo-miR to play an important role in 
facilitating the process of microRNA biomarker discovery and validation for 
cancer diagnosis and prognosis as well as for basic scientific research. 
6.2. Materials and Methods 
Oligonucleotides. MicroRNA targets and assay probes were synthesized by 




enzymatically pre-adenylated with T4 RNA ligase. Adapter and Common 
Probe (CP) are labelled with ddC and Alexa647 at their 3’ and 5’ termini, 
respectively, and were purified by HPLC. Discrimination Probes (DPs) and 
let-7a precursor DNA were labelled with phosphate at their 5’ termini and 
were PAGE-purified. Some of the microRNAs are labelled with Cy3 at their 5’ 
termini and all are PAGE-purified. The sequences of microRNAs were taken 
from miRBase (www.mirbase.org). 
Small RNA Purification from Total RNA. Total RNA extracted from human 
pancreas tissue was purchased from Life Technologies (Carlsbad, CA). Total 
RNA extracted from cell lines OE33, SKTG4, QhTRT and ChTRT were 
generously offered from Dr. Stephen Meltzer. Small RNAs were purified from 
total RNA using the mirPremier™ microRNA Isolation Kit or Qiagen 
miRNeasy Kit® combined with Qiagen RNeasy MinElute Kit®, following the 
manufacturer’s instructions. 
Ligation Assays. The assay consists of two ligation reactions. In the first step, 
microRNAs in the sample were captured in 10 uL reaction mixture using our 
previously described protocol.(87) The second step of the assay, in which CP 
and DPs were ligated together in presence of target microRNA, was 
performed by mixing 10 uL of 1st step products and 10 uL of 2nd step reaction 
master mix. The 2nd step reaction master mix consists of 1X 2nd step buffer 




microRNA target, and 40 unit of 9°N™ DNA Ligase (New England Biolabs). 
The reaction mixture was incubated at 95 °C for 30 seconds and 61 °C for 5 
minutes. The incubation was repeated for 50 times. 
PAGE Analysis. The samples were analysed on precast 15% TBE-urea 
polyacrylamide gels (Bio-Rad, Hercules, CA). 10 µL of sample was mixed with 
10 µL of loading buffer and heated for 5 minutes at 95°C. The sample was 
then loaded into the gel and run for 50 min at 300V. The separated gels were 
scanned using a Typhoon 9410 variable mode imager (GE Healthcare, 
Piscataway, NJ) and the gel images were analysed using ImageQuant (GE 
Healthcare, Piscataway, NJ). The fluorescence intensity profile of each lane 
was extracted and fit with Gaussian curves using Origin (OriginLab, 
Northampton, MA) to quantify the fluorescence intensity of the bands and 
their travel distance. 
6.3. Results 
6.3.1. Assay Principle 
The assay consists of two ligation reactions (Figure 6.1). MicroRNAs are 
naturally phosphorylated at 5’ terminal. Therefore, if template-independent 
ligase such as T4 RNA Ligase 1 is added to the target for ligation reaction, a 
significant amount of microRNA would be circularized or ligated to other 
RNAs. Such intra-/interconnected molecules are hard to detect, resulting in 




mutant of T4 RNA Ligase 2 (T4 RNA Ligase 2 truncated, K227Q) is used to 
ligate an adapter to each microRNA. The enzyme lacks the subunit which 
adds ATP to (or “adenylates”) phosphorylated DNA or RNA; however it can 
ligate the pre-adenylated DNA or RNA to the 3’ terminal of RNA. When 
optimized, this protocol can add an adapter to the microRNA in a highly 
efficient manner without significant bias, creating RNA-DNA hybrid.(87) The 
hybrid molecule serves as the target template in the second step, in which 
common probe (CP) and discrimination probes (DPs) hybridize to adapter and 
microRNA sequence of the hybrid, respectively. If CP and DP are perfectly 
hybridized to the RNA-DNA hybrid, are they ligated together by 9°N™ DNA 
Ligase and ligation product (C-D complex) is generated. CP is fluorescently 
labelled and hence so is resulting C-D complexes. The unique length indicates 
the presence of specific target microRNA while the amount of the specific C-D 
complex is proportional to the target microRNA in the original sample. The 
mixture of C-D complex is separated by gel electrophoresis, resulting in 
distinct gel bands whose fluorescence intensity can be quantified. 
6.3.2. Specificity 
In order to assess the specificity of the assay, eight of miR-let-7 family targets 
(miR-let7a, b, c, d, e, f, g, and i) were tested on Ligo-miR assay. Each miR-let-
7 family member was individually added to the reaction mixture, which 




6.2). For each lane, band intensity of each target was normalized to (divided 
by) the perfect match band. While slight breed-through of ~15% was observed 
from let-7a to f, e, and d channel and from let-7b to let-7c channel, unspecific 
detection was not observed for most of other combinations. Unspecific 
detection was even less between microRNAs from different families due to 
larger difference in sequence (Figure S6.1). 
We also verified that Ligo-miR specifically detects mature microRNA 
sequences but not precursors (Figure S6.2). MicroRNA precursor sequence of 
let-7a and technical control Circ-1 and Circ-2, two artificial sequences, were 
mixed with mature let-7a family targets. DP complementary for mature let-7 
family and Circ-1 and Circ-2 were used in the assay. The assay successfully 
detected mature microRNA and Circ-1 and Circ-2 without complication from 
precursor sequence. 
6.3.3. Purification of Small RNAs 
Ligo-miR was verified to accept both total RNA and small RNA that is 
purified from total RNA (Figure S6.3). As PAGE analysis suggest, large 
RNAs, including mRNAs among others, can be effectively eliminated by 
purification columns while minimizing loss of small RNAs (Figure S6.3A and 
B). To verify that Ligo-miR is compatible with both total RNA and purified 
small RNA, pancreas total RNA and small RNA purified from the same batch 




each detected band was plotted against each other (Figure S6.3C). The 
fluorescence intensities of each band from both samples made no significant 
difference. Since purification step can also be used as concentration step if 
less volume is added to elute the sample than the original sample volume, we 
included small RNA purification step to the standardized Ligo-miR assay 
protocol for later experiments. 
6.3.4. Sensitivity 
The assay sensitivity was assessed first using synthetic target (Figure 6.3A). 
13 of the 24 microRNA targets were comfortably detectable at as little as 
input of 1 attomoles. The fluorescence and target input were linearly 
proportional to each other, enabling accurate microRNA quantification with 
average R-square value of above 0.98.  
MicroRNAs from small input of total RNA was also detected using the assay 
(Figure 6.3B). 5 microRNAs were detectable at 24 ng of total RNA input. 
miR-92a, miR-26a, miR-17, miR-16, miR-let-7a, miR-22, miR-93 and miR-25 
were detected when 1,000 ng of total RNA was added to the reaction. 
6.3.5. The Assay Reproducibility 
The assay was repeated to assess the reproducibility (Figure 6.4). For this 
purpose, same batch of small RNA from OE33 cell line was tested on two 




highly linear regression was obtained with R2~0.998. The CV of the 
experiment was ~15%, allowing accurate microRNA quantification. 
6.3.6. Differential Expression Analysis 
The same batch of RNA was analysed using both Ligo-miR and RT-qPCR so 
as to verify the performance of Ligo-miR assay. MicroRNA expression profile 
of QhTRT, SKGT4 and ChTRT were normalized with OE33 for both assays 
and plotted against each other. High agreement was obtained with R2 value 
of 0.85 ~ 0.95. Some under-expressed microRNAs that were only detected 
with qPCR but not Ligo-miR were not included in the differential analysis. 
The experiment ensures that the microRNA expression profile obtained with 
Ligo-miR is similar to that obtained with qPCR, which is regarded as gold 
standard. 
6.3.7. Quantification of absolute microRNA copies in cell samples 
The titration curve (Figure 6.3A) allows for accurate quantification of 
microRNA within the sample. Assuming each cell has average total RNA of 
15 picogram, it is possible to quantify the number of copies of a specific 
microRNA expressed in a cell (Table 6.3). The lowest and highest copies that 
Ligo-miR detected from OE33, ChTRT, SKGT4 and QhTRT were 40 and 
6,000 copies, respectively. As expected, miR-21 was highly expressed in all 
the cell lines while RNU44, a house keeping miR, was expressed stably in all 





The proposed assay is distinguished by its sole dedication to microRNA 
targets but not any other type of biomarker. Most ligation assays proposed so 
far have been based on probe hybridization on short mature microRNA 
sequences. Such assays can be also applied to detect target sequences in 
genetic mutation, methylation or mRNA markers; however, they could suffer 
from complication of precursor microRNAs that share the same mature 
microRNA sequences but has extra overhang at the 3’ terminal. On the other 
hand, Ligo-miR has excellent specificity to detect only mature microRNA 
targets: short specific sequences without extra 3’ overhang. Stem-loop RT-
qPCR shares the same specificity for mature/precursor microRNA 
differentiation, hence leading to the excellent agreement in differential 
expression analysis between Ligo-miR and RT-qPCR.  
 Ligo-miR is sensitive enough to detect sub-attomoles (1,000,000 
~100,000 copies) of synthetic microRNA targets in a multiplexed manner 
(Figure 6.3A). For lowly expressed microRNAs that exists at 10 copies per cell, 
Ligo-miR requires total RNA from ~10,000 cells or 150 ng in total. On the 
other hand, only 1.5 ng of total RNA is required if the target microRNA is 
expressed at 1,000 copies per cell. Ligo-miR has detected microRNA targets 
from 24 ng of total RNA input, roughly corresponding to above mentioned 




 Ligo-miR detected 71% of microRNAs (59 out of 88 microRNAs) that 
was detected by RT-qPCR. Among undetected microRNas, 14 correspond to 
those that demonstrated relatively high threshold number in RT-qPCR 
reactions (Ct > 27), suggesting that such microRNAs are under-expressed in 
the sample. 
 The distinctions between Ligo-miR and qPCR are summarized in 
Table 6.2. Improved multiplexing capability demonstrated by Ligo-miR is 
beneficial not only in term of assay use, but also smaller reagent consumption 
and less demand of sample amount. Although RT-qPCR requires less sample 
per assay run, each biomarker must be tested on individual basis; hence a 
large amount of sample is necessary to test all of 24 microRNAs. This means 
that although RT-qPCR is gold standard for single biomarker analysis (e.g., 
single SNP detection), it is not designed for routine testing of panel consisting 
of multiple biomarkers (mRNA, microRNAs), for which Ligo-miR is an 




6.5. Table and Figures 
Table 6.1. Oligonucleotides. 
Name Sequence 5' -> 3' 
Adapter 5' - /5Phos/ACTGTAGGCACCATCAATC/3ddC/ - 3' 
Common Probe 
(CP) 
5' - /5Alex647N/GATTGATGGTGCCTACAGT - 3' 
DP-Circ-1 5' - /5Phos/GGGATCACTACTCTTTATACAAACTG - 3' 
DP-Circ-2 5' - /5Phos/TAGACATTCCAGGCGGTGCGTCAAACTG - 3' 
DP-RNU44 5' - /5Phos/AGTCAGTTAGAGCTAATTAAGACCAAACTG - 3' 
DP-cel-miR-39-3p 5' - /5Phos/CAAGCTGATTTACACCCGGTGATAATAAACTG - 3' 
DP-RNU6B 5' - /5Phos/AAAAATATGGAACGCTTCACGAATTTGCGTAAGTG - 3' 
DP-miR-100-3p 5' - /5Phos/CATACCTATAGATACAAGCTTGAGACGCTAATAAACTG - 
3' 
DP-miR-224-5p 5' - 
/5Phos/AACGGAACCACTAGTGACTTGCCAAAGACGCTAATAAACTG 
- 3' 
DP-miR-25-3p 5' - 
/5Phos/TCAGACCGAGACAAGTGCAATGAACCAAAGACGCTAATAAA
CTG - 3' 
DP-miR-205-5p 5' - 
/5Phos/CAGACTCCGGTGGAATGAAGGAAACAACCAAAGACGCTAA
TAAACTG - 3' 
DP-miR-93-5p 5' - 
/5Phos/CTACCTGCACGAACAGCACTTTGTTTAACAACCAAAGACGC
TAATAAACTG - 3' 
DP-miR-192-5p 5' - 
/5Phos/GGCTGTCAATTCATAGGTCAGATCTGCTATAACAACCAAAG
ACGCTAATAAACTG - 3' 
DP-miR-106b-5p 5' - 
/5Phos/ATCTGCACTGTCAGCTAGACCGTATATCTGCTTTAACAACC
AAAGACGCTAATAAACTG - 3' 
DP-miR-22-3p 5' - 
/5Phos/ACAGTTCTTCAACTGGCAGCTTGACCTTATATCCTCTTTAAC
AACCAAAGACGCTAATAAACTG - 3' 
DP-miR-345-5p 5' - 
/5Phos/GAGCCCTGGACTAGGAGTCAGCCGGAAGAATGTATATCTG
CTTTAACAACCAAAGACGCTAATAAACTG - 3' 
DP-miR-29b-3p 5' - 
/5Phos/AACACTGATTTCAAATGGTGCTATTCTCTCGAAGACCGTAT
ATCTGCTTTAACAACCAAAGACGCTAATAAACTG - 3' 
DP-let-7a-5p 5' - 
/5Phos/AACTATACAACCTACTACCTCAACTTTGCTTCTCTCGAAGAC
CGTATATCTGCTTTAACAACCAAAGACGCTAATAAACTG - 3' 







DP-miR-155-5p 5' - 
/5Phos/ACCCCTATCACGATTAGCATTAATTCTGTGGGCTAGACTTT
GCTTCTCTCGAAGACCGTATATCTGCTTTAACAACCAAAGACGCTA
ATAAACTG - 3' 
DP-miR-16-5p 5' - 
/5Phos/CGCCAATATTTACGTGCTGCTAGGATGGATATTCTGTGGGC
TAGACTTTGCTTCTCTCGAAGACCGTATATCTGCTTTAACAACCAA
AGACGCTAATAAACTG - 3' 
DP-miR-17-5p 5' - 
/5Phos/CTACCTGCACTGTAAGCACTTTGAATATACTTGATGCATATT
ATCTGGGCTAGACTTTGCTTCTCTCGAAGACCGTATATCTGCTTTA
ACAACCAAAGACGCTAATAAACTG - 3' 
DP-miR-15a-5p 5' - 
/5Phos/CACAAACCATTATGTGCTGCTTCCAACACGAACAATACCAT
GGATGGATATTCTGTGGGCTAGACTTTGCTTCTCTCGAAGACCGTA
TATCTGCTTTAACAACCAAAGACGCTAATAAACTG - 3' 









GCTAATAAACTG - 3' 




AACAACCAAAGACGCTAATAAACTG - 3' 
let-7a 5' - /5Cy3/rUrGrArGrGrUrArGrUrArGrGrUrUrGrUrArUrArGrUrU - 3' 
miR-16 5' - /5Cy3/rUrArGrCrArGrCrArCrGrUrArArArUrArUrUrGrGrCrG - 3' 
miR-21 5' - /5Cy3/rUrArGrCrUrUrArUrCrArGrArCrUrGrArUrGrUrUrGrA - 3' 
miR-26a 5' - /5Cy3/rUrUrCrArArGrUrArArUrCrCrArGrGrArUrArGrGrCrU - 3' 
miR-29b 5' - /5Cy3/rUrArGrCrArCrCrArUrUrUrGrArArArUrCrArGrUrGrUrU - 
3' 





ACCACTGGGAGATAACTATACAATCTACTGTCTTTCCTA - 3' 
circ-1 5' - rGrUrArUrArArArGrArGrUrArGrUrGrArUrGrGrG - 3' 
circ-2 5' - rGrArGrGrGrArGrGrGrGrGrUrGrGrArArUrGrUrGrUrA - 3' 
SNORD44 5' - rArGTrGrArGTTrArGrArGrGTrArATTrArArGrArGrG - 3' 
cel-miR-39-3p 5' - rUrGrArGrGrGrGrGrUrGrUrArArArUrGrArGrGrUrUrG - 3' 






miR-100-3p 5' - rGrArArGrGrUrUrGrUrArUrGrUrArUrArGrGrUrArUrG - 3' 
miR-224-5p 5' - rGrArArGrUrGrArGrUrArGrUrGrGrUrUrGrGrGrUrU - 3' 
miR-25-3p 5' - rGrArUrUrGrGrArGrUrUrGrUrGrUrGrGrGrUrGrUrGrA - 3' 
miR-205-5p 5' - rUrGrGrUrUrGrArUrUrGrGrArGrGrGrGrArGrUrGrUrG - 3' 
miR-93-5p 5' - rGrArArArGrUrGrGrUrGrUrUrGrGrUrGrGrArGrGrUrArG - 3' 
miR-192-5p 5' - rGrUrGrArGrGrUrArUrGrArArUrUrGrArGrArGrGrG - 3' 
miR-106b-5p 5' - rUrArArArGrUrGrGrUrGrArGrArGrUrGrGrArGrArU - 3' 
miR-22-3p 5' - rArArGrGrUrGrGrGrArGrUrUrGrArArGrArArGrUrGrU - 3' 
miR-345-5p 5' - rGrGrUrGrArGrUrGrGrUrArGrUrGrGrArGrGrGrGrUrG - 3' 
miR-29b-3p 5' - rUrArGrGrArGrGrArUrUrUrGrArArArUrGrArGrUrGrUrU - 3' 
let-7a-5p 5' - rUrGrArGrGrUrArGrUrArGrGrUrUrGrUrArUrArGrUrU - 3' 
miR-21-5p 5' - rUrArGrGrUrUrArUrGrArGrArGrUrGrArUrGrUrUrGrA - 3' 
miR-155-5p 5' - rUrUrArArUrGrGrUrArArUrGrGrUrGrArUrArGrGrGrGrU - 3' 
miR-16-5p 5' - rUrArGrGrArGrGrArGrGrUrArArArUrArUrUrGrGrGrG - 3' 
miR-17-5p 5' - rGrArArArGrUrGrGrUrUrArGrArGrUrGrGrArGrGrUrArG - 3' 
miR-15a-5p 5' - rUrArGrGrArGrGrArGrArUrArArUrGrGrUrUrUrGrUrG - 3' 
miR-34a-5p 5' - rUrGrGrGrArGrUrGrUrGrUrUrArGrGrUrGrGrUrUrGrU - 3' 
miR-26a-5p 5' - rUrUrGrArArGrUrArArUrGrGrArGrGrArUrArGrGrGrU - 3' 






Table 6.2. Comparison between Ligo-miR and RT-qPCR. 
  
Taqman RT-qPCR Ligo-miR EZ
Assay Format 1-plex
1 microRNA per reaction
24-plex
24 microRNA per reaction
Assay Step 1 Applied Biosystems Taqman RT Kit
Applied Biosystems Taqman microRNA Assay
22 reactions per sample
Capture Ligation Master Mix
1 reaction per sample
Assay Step 2 Bio-rad iQ Supermix
Applied Biosystems Taqman microRNA Assay
22 reactions per sample
Coding Ligation Master Mix
1 reaction per sample
RNA Needed Per 
Sample
22 reactions x 100 ng per reaction x 3
= 6.6 g per sample
1 reaction x 500 ng per reaction x 3
= 1.5 g per sample
4x Sample Reagent
Cost
$78 per sample x 4 samples x 3
= $936 total
$20 per sample x 4 samples x 3
= $240 total (proj. retail cost)
4x Sample Reactions 
Performed
22 reactions per sample x 4 samples x 3 
= 264 reactions total
1 reaction per sample x 4 samples x 3 
= 12 reactions total
4x Sample Analysis 
Time
5.5 h hands-on prep-time 
+ 9 h machine time
0.5 h hands-on prep-time




Table 6.3. Absolute quantification of microRNA 
MicroRNA copies per cell was calculated using titration curve (Figure 6.3A). 
 OE33 ChTRT SKGT4 QhTRT 
miR-92a-3p 503 724 615 544 
miR-26a-5p 443 832 335 329 
miR-34a-5p 0 0 0 39 
miR-15a-5p 686 940 628 260 
miR-17-5p 633 629 623 500 
miR-16-5p 1345 1364 1057 594 
miR-155-5p 0 0 0 0 
miR-21-5p 6020 4101 3625 1457 
let-7a-5p 1688 3630 2435 1279 
miR-29b-3p 3041 651 699 439 
miR-345-5p 0 0 0 0 
miR-22-3p 276 475 547 137 
miR-106b-5p 1002 185 227 86 
miR-192-5p 0 0 0 0 
miR-93-5p 398 79 100 55 
miR-205-5p 341 0 0 40 
miR-25-3p 471 163 148 60 
miR-224-5p 0 0 0 0 
miR-100-3p 0 0 0 0 
RNU6B 3415 1878 2928 176 
cel-miR-39-3p 0 0 0 0 
RNU44 2886 2957 2384 1574 
crc-2 6055 5230 4863 4098 






Figure 6.1. Assay principle.  
The assay is comprised of two ligation steps. MicroRNAs within the sample 
are first ligated to pre-adenylated adapter using T4 RNA Ligase 2 truncated 
K227Q to generate RNA-DNA hybrid, which serves as the target template in 
the second step. In the second step, common probe (CP) and discrimination 
probes (DPs), respectively, hybridize to adapter and microRNA sequences of 
the RNA-DNA hybrid. CP is fluorescently labeled at its 5’ terminal. 
Depending on the number of microRNA that is targeted by the assay, 
multiple DPs, each having unique recognition sequence for target microRNA 
and different lengths of Variable Length Coding Sequence (VLCS), are added 
to the reaction. Only if CP and DP are perfectly hybridized to the RNA-DNA 
hybrid, are they ligated together by 9°N™ DNA Ligase to generate ligation 
product (C-D complex) with unique length indicating the presence of the 
target microRNA. The mixture of C-D complexes are separated by denaturing 
PAGE, generating barcode patterns under fluorescence gel scanner. The band 
position and fluorescence intensity indicate the identity and amount of 



























































Figure 6.2. Specific detection of miR-let7 family.  
(A) Each of microRNA let-7 family (a, b, c, d, e, f, g, and i) target was tested 
individually. (B) The bands detected from each lane were normalized to the 
correct detection. The assay was highly specific with maximum crosstalk of 
only as much as 16%. (C) Sequences of let-7 family microRNAs. Sequences 
differences are highlighted with green on let-7a and red on let-7b to let-7i. let-














let-7i - - - - - - - 100%
let-7g - - - - - - 100% -
let-7f 14% - - - - 100% - 4%
let-7e 4% - - - 100% - 4% -
let-7d 9% - - 100% - - - -
let-7c - 16% 100% - - - - -
let-7b - 100% - - - - - -

























Figure 6.3. Sensitivity assessment.  
(A) Synthesized microRNAs varying from 100 to 1 attomoles were added to 
the reaction. The fluorescence signal of the 24 ligation products were linearly 
proportional to the amount of input target microRNA. (B) RNA purified from 
1,000 ng to 24 ng of total RNA extracted from pancreas were added to the 
reaction.  There was a large variation between the amounts of microRNA 

















































Figure 6.4. Assay reproducibility.  
RNA from OE33 cell line was tested with two separate experiments. 
Fluorescence intensity of each detected microRNA bands from the two 
experiments was plotted against each other, resulting in a highly linear 
relationship. The assay was highly repeatable with correlation coefficient (R2 

































Figure 6.5. Comparison plots of Ligo-miR to RT-qPCR assay.  
Log10 (microRNA expression level in Cell Line 1 / microRNA expression level 
in Cell Line 2) was measured by Ligo-miR and RT-qPCR. Signals from cell 
line ChTRT, SKGT4 and QhTRT were normalized against signals from OE33. 
No normalization was conducted within individual cell lines. The correlation 
coefficients was 0.9487, 0.8548, and 0.9172, for ChTRT, SKGT4, and QhTRT , 
























































6.6. Supplementary Information 
Figure S6.1. Cross-family detection of microRNA. 
Assessment of the assay specificity for microRNA targets in different families. 
MiR-34a, let-7a, miR-29b, miR-16, miR-26a, and miR-21 bands were detected 






























Figure S6.2. Specific detection of mature microRNA.  
let-7a precursor microRNA was spiked as background molecules into a pool of 
mature let-7 family microRNA and technical control Circ-1 and Circ-2. 
Mature let-7 family microRNAs were added at decreasing concentration 
(1,000 attomole to 0 attomole) while Circ-1 and Circ-2 as well as let-7a 
precursor were kept at 100 attomole. DP for mature let-7 family microRNA 
and Circ-1 and Circ-2 were used. Sub-attomole of mature microRNAs were 
detected without complication from let-7a precursor (not detected due to 
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Figure S6.3. Small RNA and total RNA as target for Ligo-miR.  
(A) Purification of small RNA from total RNA. Large RNAs are eliminated 
using the mirPremier™ microRNA Isolation Kit. RNAs are stained with 
SYBR Safe®. (B) Fluorescence intensity profile of purified (green line) and 
non-purified (blue line) total RNA. Only small RNAs remain after 
purification. (C) Result of Ligo-miR assay using purified and non-purified 
total RNA. The two samples resulted in similar microRNA expression profile 
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Chapter 7: Conclusion and Future Directions 
In this thesis, I have developed ligation assays for DNA and RNA biomarkers. 
Ligation technologies not only provide excellent specificity but also are easily 
incorporated to multiplexed assays, both are essential characteristics for 
biomarker detection. As more multiplexed assays replace single-plex assays 
in the future, ligation-based methods discussed in this thesis, Ligo-miR 
especially, could serve as prototype biomarker detection assays to be used in 
wide range of research labs or even in clinical settings.  
 By including universal PCR primer region in DP and CP, all ligation 
products could be amplified within single tube simultaneously. Combining 
the benefit of PCR-level sensitivity and multiplexing capability of Ligo-miR, 
such an assay would be powerful enough to enable multiplexed microRNA 
detection from smaller amount of RNA input, from body fluids such as serum 
or plasma, or even from single cells.  
 The assay can be automated by changing the last PAGE analysis step 
to capillary electrophoresis or single-molecule free solution hydrodynamic 
separation (SML-FSHS) invented by our group.(141) Such automation is 
critical, making Ligo-miR accessible to wider audience. For the assay to be 
useful as diagnostic/prognostic tool, however, a set panel of microRNA 
biomarkers needs to be discovered and approved by Food and Drug 




as a highly promising biomarker class that potentially elucidates the patient 
cancer status as well as classifies cancer type, we believe the microRNA 
biomarker would be continuously investigated by labs all over the world. 
Ligo-miR could play a great role as a powerful tool kit for their important 
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